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Cell differentiation is a complex process orchestrated by sets of regulators appearing at 
precise temporal points, resulting in regulatory cascades that affect the expression of 
broader sets of genes, ending up in the formation of different tissues and organ parts. The 
identification of stage-specific master regulators and the mechanism by which they activate 
each other is a key to understanding and controlling differentiation and still a challenging 
quest, particularly in the fields of tissue regeneration and organoid engineering.   
 
To tackle this quest I developed a novel workflow and a model I call the Temporal Regulatory 
Cascade (TRC). The TRC workflow combines a comprehensive general regulatory network 
based on binding site predictions with user-provided temporal gene expression data, to 
generate a series of connected stage-specific regulatory networks. The TRC identifies those 
regulators that are unique for each time point and the regulatory interactions between them, 
taking into consideration the temporal order of their appearance. The TRC model is 
represented in the form of a regulatory cascade that shows the emergence of these regulators 
and regulatory interactions across time. The TRC workflow was implemented in the form of 
a user-friendly tool with a visual web interface that requires no expert knowledge in 
programming or statistics, making it directly usable for scientists with no strong 
computational background. In addition to generating TRCs, the tool links multiple interactive 
visual workflows, in which a user can track and investigate further different regulators, 
target genes, and interactions, directing the tool along the way into biologically sensible 
results based on the given dataset.  
 
The workflow was used to analyze a high-quality dataset that documents the gene 
expression levels across multiple time points during the differentiation of stem cells into 
mature cardiomyocytes. In addition to the main dataset, we applied the TRC model to several 
different time-series expression datasets coming from different contexts such as neural 
development. The model was successful in identifying previously-known and new potential 
key regulators, in addition to the particular time points to which these regulators are 
associated. These results were highly supported by GO enrichment, experimental knowledge 
and literature. Compared to other methods, our approach showed an advantage in terms of 
computational time, and the density of the important regulators identified in such small 








Die Differenzierung von Zellen ist ein komplexer Prozess, welcher durch eine Reihe von 
Regulatoren geleitet wird. Das temporäre Auftreten ist genau abgestimmt ist und wird durch 
zusammen regulatorische Signalkaskaden gesteuert, die die Expression von Genen 
beeinflussen und damit letzten Endes zur Bildung von unterschiedlichen Geweben und 
Organen führt. Die Identifikation von Zustands-spezifischen Masterregulatoren und deren 
gegenseitige Aktivierung ist einer der Schlüsselaspekte um, Zelldifferenzierung verstehen 
und kontrollieren zu können und ist gegenwärtig eine herausfordernde Aufgabe in den 
Gebieten der Gewebsregeneration und  Organzüchtung. 
Um diese Herausforderung anzugehen, habe ich einen neuen Workflow und das Modell 
Temporal Regulatory Cascade (TRC) entwickelt. Der TRC-Workflow kombiniert ein 
allgemeingültige globales regulatorisches Netzwerk, dass auf der Vorhersage von DNA-
Bindungsstellen basiert, um auf Basis von Benutzern zur Verfügung gestellten 
Expressionsdaten von Zeitreihenexperimenten Signalkaskaden von zusammenhängenden 
zeitpunktspezifischen, regulatorischen Netzwerke zu erstellen. Der TRC-Workflow 
identifiziert exklusive Regulatoren für einen bestimmten Zeitpunkt, sowie deren 
regulatorisches Zusammenspiel, wobei das zeitliche Auftreten der Regulatoren 
berücksichtigt wird. Das TRC-Modell wird in Form einer regulatorischen Kaskade 
repräsentiert, die das Auftreten und die regulatorischen Interaktionen der Regulatoren über 
die Zeit hinweg darstellt. Der TRC-Workflow wurde als benutzerfreundliches Programm 
inklusive einer Weboberfläche implementiert, welche ohne großes Expertenwissen in 
Informatik oder Statistik verwendet werden kann. Zusätzlich zur Erstellung von TRCs 
verbindet das Programm mehrere interaktive Workflows in denen Nutzer unterschiedliche 
Regulatoren, Zielgene und Interaktionen identifizieren können. 
Der TRC-Workflow wurde angewendet, um einen hochqualitativen Datensatz zu 
analysieren, der die Genexpressionsstärken zwischen einer Vielzahl an unterschiedlichen 
Zeitpunkten der Differenzierung von Stammzellen in reife Herzmuskelzellen abbildet. 
Zusätzlich zu diesem Datensatz, habe ich das TRC auf  mehrere Zeitreihen-Expressionsdaten 
von unterschiedlichen Hintergründen, wie zum Beispiel die neuronale Entwicklung 
angewendet. Das Modell hat erfolgreich bereits bekannte und neue potentielle 
Masterregulatoren in den Zeitpunkten zu denen diese Regulatoren ursprünglich zugeordnet 
wurden identifiziert. Die Ergebnisse wurden mit Hilfe von GO-Enrichment, Expertenwissen 
und Literaturstudien belegt. Im Vergleich zu anderen Methoden zeigt mein Ansatz einen 
Vorteil hinsichtlich Rechenzeit und der Dichte der identifizierten Regulatoren in kleinen 
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Cell differentiation, the driving force in development, is responsible for the diversity of cell 
types and organs that is behind the complexity of eukaryotic organisms. Orchestrating such 
precise differentiation events is the work of a set of complex regulatory programs that exert 
the needed control on the timing, cell type, and spatial coordinates of the differentiating cells. 
Typically, a handful of master regulators start the regulatory mechanism that results in the 
activation or repression of other regulators and non-regulatory genes, which by themselves 
express proteins that lead to the activation or repression of other genes.  These regulatory 
waves emerge in exact temporal order and pace, to give rise, through consecutive unique 
stages, to different cell types and tissue layers that end up forming complex functioning 
organs. Our understanding of such regulatory programs and their dynamics is still in its 
infancy. However, a massive wave of scientific interest and research has been ongoing 
recently to decode and reverse engineer such programs. 
 
The wave of cell differentiation research started mainly with the discovery of induced 
pluripotent stem cells (iPSCs), that coincided with the decreasing prices of genetic high-
throughput methods such as RNA-Seq. Through this wave, medical applications based on 
manipulating cell differentiation emerged and experiments geared towards developing stem 
cell therapies and organoid engineering became increasingly popular. Scientists were able 
to run various differentiation experiments and take transcriptional snapshots of tens of 
thousands of genes at different time points of the experiment. These experiments led to the 
generation of a significant number of temporal gene expression datasets that needed to be 
analyzed to provide a basis to reconstruct the underlying regulatory programs that drove 
this expression.  
 
Various computational approaches were applied to analyze such sets, and most of them aim 
at either identifying a candidate list of genes or deriving relevant gene regulatory networks 
(GRNs). However, both quests turned out to be challenging, as these general methods do not 
take into consideration the unique properties of cell differentiation. Candidate gene lists 
generated by methods such as those that identify differentially expressed genes (DEGs) were 
usually long and contained only few context-relevant regulators and genes, which is a 
challenge for the experimentalists that usually look for concise sets of candidates for 
experimental verifications. Methods for constructing gene regulatory networks from these 
temporal datasets suffered from challenges such as excessive computational time, and the 
considerable difference between the number of the genes under study, usually in the order 




typically less than ten. In addition to that, the results of the constructed GRNs were large 
networks of thousands of nodes and hundreds of thousands of interactions, which are hard 
to distill into useful starting points for experimentalists. 
 
As these gaps in these computational approaches persisted, I decided to take the challenge 
of developing a method to reconstruct transcriptional regulatory programs in the context of 
cell differentiation. To tackle this challenge, I needed to create a model and a workflow that 
can do the following: 
• Integrates protein-DNA binding information 
• Integrates temporal gene expression data effectively 
• Utilizes the temporal order and integrates into a cascade-like architecture  
• Identifies stage-specific master regulators 
• Proves to be biologically relevant 
• Generates concise, information-dense results 
• Is computationally efficient  
• Can be used by experimentalists with no computational background 
 
Based on these points, I developed a model and a workflow that constructs a series of concise 
interconnected stage-specific regulatory networks that form a temporal cascade. This model, 
which I call the Temporal Regulatory Cascade (TRC) model, uses time-series gene expression 
data combined with a comprehensive regulatory network based on transcription factor 
binding site predictions to generate the regulatory cascade. In this cascade architecture, 
stage-specific regulators are identified based on their expression pattern and placed 
accordingly in their temporal order, and then relevant regulatory interactions are queried 
from the background network. The model gives a glimpse on the emergence and 
disappearance of the regulatory waves across time, as well as the potential role of particular 
regulators within these waves. This workflow was implemented in the form of a web service 
where a user can upload his own time series dataset and automatically get a visual 
representation of the custom regulatory cascade based on the relevant experiment. The web 
service included other workflows that allow the user to explore aspects of co-expression and 
co-regulation in his dataset interactively, to obtain biologically sensible results. The web 
service is fast, user-friendly, visual and easily usable by scientists with no statistical or 
programming background and is publicly available at http://tf-investigator.sybig.de/TRC. 
 
In order to investigate the ability of this method to deliver biologically sensible results, I 
applied the TRC workflow to construct a cardiac differentiation regulatory cascade based on 
a high-quality dataset that is generated from an experiment that monitored the 
differentiation of stem cells to mature cardiomyocytes. The workflow was successful in 




role during differentiation, as well as identifying new potential regulators that might 
enhance the differentiation process. The workflow was also applied to various datasets and 
cell differentiation contexts, and consistently had similar positive results which were 
analyzed in details and compared with the existing literature and experiments, to merely lay 
in place some pieces of the big puzzle of developmental biology. 
 
1.1 Thesis Structure 
The remainder of this thesis is structured as follows. In Chapter 2, I present an overview of 
the biological facts and mechanisms that provided the basis for the work done as well as the 
current and potential medical applications of manipulating cell differentiation. In Chapter 3, 
I go through some of the main state of the art computational approaches that share common 
aims with the model I developed, such as regulatory network inference methods and 
approaches for analyzing temporal gene expression, highlighting the advantages and 
disadvantages of these methods and tools. In Chapter 4, I introduce the main material and 
methods that were used throughout the thesis, such as experimental methods, databases, 
software libraries, tools and data sources. Afterwards, I present the main results of my PhD 
work, from enhancing some existing methods to developing the novel TRC model and the 
accompanying web tool to applying the developed workflows to several data sets and 
evaluating the results from a biological point of view. This is followed by a discussion in 
Chapter 6, which covers aspects such as optimizing the model evaluating its significance and 
comparing it to other existing comparable tools. The thesis ends with a conclusion part that 









I published the TRC model with the accompanying tool in addition to applying it to analyze 
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2 Biological Background 
Throughout millions of years of evolution, from the simple single-celled organisms to the 
more complex eukaryotic organisms, biological systems became more diverse and complex.  
Understanding and reverse engineering elements of such systems have always been the 
pursuit of biologists throughout history.  With the discovery of microscopes, a whole world 
opened for scientists, the world of a cell.   From that point on, a succession of discoveries led 
to a deeper understanding of cellular components and cell division. The next breakthrough 
was with the discovery of the DNA’s (Deoxyribonucleic Acid) structure, by James Watson and 
Francis Crick. Genetics took another leap; thousands of researchers went on quests that 
unraveled different aspects and complexities and gave rise to a set of new biological 
questions.  In the following subsections, we introduce some basic yet essential biochemical 
components and concepts that lay the bedrock for the research done in this manuscript. 
 
2.1 The Genomic Organization 
Deoxyribonucleic acid (DNA), which is considered to be the blueprint for living things, is a 
molecule that contains information used in everyday metabolism and enables cells to 
develop and work together to form a fully functional body. A given DNA strand contains a 
sequence of bases: Adenine (A), Guanine (G), Cytosine (C), and Thymine (T). These bases pair 
up with each other, A with T and C with G, to form units called base pairs. Each base is also 
attached to a backbone of sugar and phosphate molecules.  A nucleotide refers to the 
combination of a base along with a sugar and a phosphate moiety. Those nucleotides are 
pieced together in two long strands forming a spiral called a double helix (Figure 1).  
 
        
 
Figure 1. (Left) The structure of the DNA with the different base pairs forming the double helix  




In a eukaryotic cell, the DNA is packaged tightly to prevent it from being damaged and the 
strands from being entangled. For this packaging, the cell uses histones, positively charged 
proteins, around which the negatively charged DNA wraps forming complexes called 
nucleosomes. Nucleosomes fold up to form the chromatin fiber, which is compressed, folded, 
and coiled, forming the chromatid of a chromosome. 
A gene is a section of the DNA that can range from hundreds to millions of base pairs that 
carry the instructions for the synthesis of a product that could be RNA or protein. A gene has 
a Transcription Start Site (TSS) that indicates the beginning of the gene and a transcription 
stop site that marks its end. A gene has also a start codon and a stop codon, its importance 
covered in the next section. Upstream from each gene is a promoter region, where certain 
regulators can bind to the DNA and control the activity of the associated gene. (Figure 2) 
 
 
Figure 2. The genomic composition around a gene, with the promoter region upstream from 
the TSS and the transcription stop site in the end. 
 
2.2 Mechanisms of Gene Expression 
 
Since the DNA is merely a blueprint, genes still have to undergo a process in which their code 
is read and used to produce corresponding proteins upon which the cell and the whole 
organism would function. For this to happen, two main steps have to occur, transcription 
and translation. 
The main molecule involved in these processes is the RNA (Ribonucleic Acid), which is a 
polymer similar to the DNA in some aspects (Figure 1). It is made out of a single strand of 
nucleotides that can fold on itself. The sequence of bases similar to that of the DNA for the 




than DNA polymers, not exceeding a few thousand base pairs in length.  Different types of 
RNA, such as messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA), 
play different roles in the regulation and protein synthesis. 
Transcription is the process by which an RNA molecule is synthesized using a DNA segment 
as a template. This process starts with an enzyme called RNA polymerase binding to the 
promoter of a gene, separating the DNA strands and adding matching RNA nucleotides to 
one of them. The transcription ends with the newly synthesized RNA strand separating, to 
be later translated into proteins. (Figure 3) 
 
 
Figure 3. The process of transcription in action. The RNA polymerase separating the DNA 






Figure 4. The process of translating an mRNA segment. The ribosome assembling itself around 
the mRNA and tRNAs binding to matching codons extending the amino acid chain. 
 
Translation is the process of synthesizing proteins based on mRNA templates. It goes 





Initiation: The ribosome initiates the translation assembling itself around the mRNA, and a 
tRNA carrying the amino acid methionine attaches itself to the matching codon AUG, known 
as the start codon.  
 
Elongation: It is the stage where the amino acid polypeptide chain is extended, one amino 
acid at a time. A tRNA binds to a new codon, and the carried amino acid is linked to the 
existing chain. The next codon in the mRNA is then exposed for reading, and the process 
repeats. 
 
Termination: When the ribosome encounters a stop codon, it starts the process of 
separating the chain from the tRNA and ejects it out.  
 
 Afterwards, the polypeptide chain goes on to fold into a 3D shape or combines with other 
polypeptides forming a functional protein (Figure 4). 
 
 
2.3 Gene Regulation 
Despite having the same DNA, cells within the same organism differ in terms of their type, 
shape, functions and the proteins synthesized. And despite being present in the code, not all 
genes are expressed at the same time and conditions; they are rather used selectively by 
regulatory mechanisms. Gene regulation is the mechanism by which gene expression is 
controlled, either positively by activating the gene or negatively by repressing its expression. 
Regulation in most genes can occur at one or more of the following levels: 
 
Chromatin level: The accessibility of the chromatin is a determining factor of whether a 
gene gets expressed or not. Open chromatin around the region of the gene makes it possible 
for regulators and the transcription machinery to access and start transcribing the gene, 
while a tightly packed one can be a barrier. 
 
Transcriptional level: It is the primary regulatory level and the main focus of this 
manuscript. The leading players in the transcriptional regulation are transcription factors 
(TFs). 
 A TF is a protein that has the affinity to bind to the DNA, particularly in the promoter regions 




DNA-binding domain (DBD) of the TF matching a particular associated nucleotide pattern in 
the DNA called a binding site. Many genes are regulated by several transcription factors, with 
a specific combination needed to turn the gene on. TFs, in a way, allow the cell to use 
molecular logic and process information to turn on and off genes depending on the type of 
the tissue, environmental stress, and many other variables. 
 
 
Figure 5. Elements of the proximal and distal regulatory mechanisms in action. Some 
regulatory proteins binding to the promoter and others binding further away but bending the 
DNA accordingly to contribute to the regulatory complex. 
 
Post-transcriptional level: mRNA segments resulting from transcription undergo different 
modifications before they reach the translation stage. Manipulations such as capping, slicing, 
alternative splicing, editing, and the addition of poly(A) tail to the RNA segment, regulate the 
final sequence, availability, and half-life of the mRNA that is ready for translation. MiRNAs 
are small RNAs that have the capability to bind to mRNA segments and chop them, effectively 
suppressing the expression of the corresponding gene. Depending on how well it matches in 
its binding to the mRNA, sometimes miRNAs can block the process of translation of an mRNA 
segment rather than causing its degradation. 
 
Protein level: Proteins undergo editing, cleaving, and folding with the help of various other 
molecules, which affects their activity and behavior. Phosphorylation is another common 
post-translational regulatory mechanism, where a phosphate group attaches to a protein 






2.4 Cell Differentiation 
 
Cell differentiation is the process in which cells change their type, functionally or 
morphologically, as they divide and multiply. Differentiation is the essence of eukaryotic 
development, where cells multiply and morph into drastically different types in the right 
time and place, giving the rise for different types of tissues and organs. Most cells are 
originally derived from stem cells. 
Stem cells are cells that have the ability to differentiate into different specialized cell types. 
These special cells are usually of embryonic origins, prominently found in the cell mass and 
blastocysts during the early stages of development. Stem cells can also be obtained after 
development, through the blood from the umbilical cord after birth, or even the bone 
marrow, adipose, or the blood of an adult, and referred to as somatic stem cells in such cases. 
Embryonic stem cells, which are typically hard to obtain, are pluripotent, meaning they have 
the ability to differentiate into any cell type. While somatic stem cells, though much easier to 
obtain and isolate, are multipotent, meaning they can differentiate only into particular 
closely related cell types. 
In the year 2002, Shinya Yamanaka made a breakthrough by discovering a method to 
produce pluripotent stem cells from fibroblasts by adding a small set of TFs (Myc, Oct3/4, 
Sox2, and Klf4), reverting these adult cells into a pluripotency stage [1]. This discovery led 
to a development in the induced pluripotent stem cell research and later through the years, 
multiple groups of researchers successfully generated better and better qualities of iPSC.  
Scientists later utilized these iPSCs and differentiated them into different types of cells such 
as neural cells and even reprogramming them to create a whole organ such as a liver. Stem 
cells proved to be a handy tool to study development, differentiation, and gene regulation. 
However, in order to understand and effectively manipulate stem cells, a deep 
understanding of the regulatory mechanism that governs cell differentiation is necessary.  
 
 
2.5 Medical application 
One of the biggest motivations that have driven scientists throughout history to understand 
the human body was to overcome common diseases. Nowadays, a handful of diseases are 
responsible for most of the deaths in the world and constitute the most prominent challenges 
to our health. Surpassing cancer, chronic respiratory diseases, and diabetes, cardiac related 
diseases contribute annually to more deaths than any other disease (Figure 6). It is estimated 
that around 17.9 million people die each year because of heart-related issues. A myocardial 




fatal, and around 320 billion dollars are spent annually on these issues by the health care 
system in the US alone. Those staggering numbers have motivated more medical and 
biological research in the direction of understanding the cardiovascular diseases and the 
heart on all levels.  Harnessing that knowledge into a medical application that can save 




Figure 6. Top ten global causes of deaths and their associated number of deaths in 2016. The 
dominance of cardiac related diseases is outstanding. 
One major approach for the treatment of cardiac diseases has been through the use of drugs 
such as beta-blockers or various calcium channel blockers. However, this approach is 
inadequate to restore cardiac function. A heart transplant is another way of dealing with 
heart failure, but its impracticality is evident when it comes to providing enough hearts for 
the millions that need it, aside from the other problems such as the high risk of rejection. 
Devices such as the Implantable cardioverter defibrillator (ICD) or Left ventricular assist 
device (LVAD) can be used to temporarily enhance cardiac function in the case of heart 
failure, but they are expensive, cumbersome and entail many complications and problems. 
 
 
The main reason behind the high rates of cardiovascular diseases is the fragile nature of the 
human heart. Despite its efficiency in pumping blood to meet the demands of the different 
tissues and organs of the body, the function of the human heart can easily and fatally be 
disrupted. For example, in the case of myocardial infarction, the blood flow to a portion of 
the heart is blocked through a cholesterol blockage, which leads to the death of billions of 
heart muscle cells within hours.  These muscle cells are replaced by a scar, and this causes 
dilation of the left ventricular chamber, and its ability to contract and squeeze blood is 
compromised, causing eventually heart failure.  Impacts like these lead to a series of changes 















in the structure and function of the heart that include fibrosis, which causes stiffening of the 
heart loss of pump function and cardiac arrhythmia, where the heart develops an abnormal 
electrical beat, and ultimately these changes can culminate in complete heart failure or 
sudden death. 
 
This would not have been as big of a problem if the heart had regenerative properties like 
other organs such as the human liver or skin.  For example, if you cut the human skin, it can 
repair itself completely seamlessly, so does the liver if one surgically removes fifty percent 
of it, the rest will grow back a completely new liver exactly the same size and structure as 
the original liver.  That mechanism has been lost in the hearts of mammals, including 
humans, leaving the adult human heart unable to generate new heart muscle cells and repair 
itself. However, some organisms like fish and salamanders have remarkable regenerative 
powers. If, for example, the fins, the legs or the tail of a salamander or a fish are amputated, 
they will grow back the limb to exactly the same size, structure, and function as the original 
limb, and interestingly the same goes for their heart. If half of the heart of a salamander or a 
fish is surgically amputated, they will grow the heart right back to the exact same size and 
structure. While this feature is not present in adult mammals, scientists discovered that neo-
fetal mice displayed the ability to regenerate their hearts. Newly born mice were taken, and 
twenty percent of the apex of their heart was surgically amputated, remarkably it was found 
that these hearts could completely regenerate back to normal (Figure 7). On the first day they 
observed a clot formation plugging the leak in the ventricle, then on day two they saw 
inflammation of this region, by day 7 they found muscle cell proliferation, and by day 21 
there was a complete disappearance of the wound and the heart was completely restored to 
normal structure and function. However, if the amputations are delayed and the heart was 
injured one week after birth, the regenerative process starts to diminish, and more delay 
would cause a bigger scar and less regeneration. This experiment is quite important because 
it indicates that the mechanisms, genes, proteins, and signals that are required to regenerate 
the heart really do exist in a mammal such as a mouse and presumably in a human, but 
somehow these are silenced later in life [2]. This leads to the hypothesis that there must be 
biological pathways, genes, and mechanisms that can do this regeneration and raised the 
question of why  they are switched off in the adult part of humans.  Finding the biochemical 







Figure 7. (Left) Adult zebrafish regenerating cardiac muscle lost from resection of the 
ventricular apex. (Middle) Neonatal mice showing a regenerative response to cardiac injury 
(Right) Adult mice show minimal regeneration in response to injury (based on a figure from 
[2]).  
New approaches emerged to harness stem cell technology, and developments on the medical 
application level have been made in the past years. Cardiomyocytes derived from iPSCs are 
used as patches that are transplanted into affected areas of the heart (Figure 8). However, this 
approach still faces many challenges and still requires optimization. The heart is highly 
electrically integrated, and the disruption of this electrical integration by injecting foreign 
cells into the heart can cause arrhythmias, where the new cells will be pulsing at a different 
rate and intensity than the rest of the heart.  Adjusting such variables and tuning in the cells 
requires additional extensive research and further experimentation to decode the exact 






Figure 8. Using stem cell-derived cardiomyocytes for cardiac regeneration. Stem cells are 
differentiated into mature cardiomyocyte, assisted with synthetic or natural scaffolds, which 
are transplanted cardiomyocytes into the affected area in the heart to stimulate re-growth. 
 
Ultimately, the aim of medical research in this field is to find a way to directly reprogram 
resident fibroblasts that exist in the human heart, via manipulating genetic and regulatory 
programs using factors and drugs, turning them into cardiomyocyte-like cells, without the 
need of a surgery or a transplant. To reach this point, medical research is aimed towards 
understanding cardiac differentiation on a deep molecular level, and currently, large funds 










3 Bioinformatics Background 
 
3.1 Regulatory Networks 
Gene regulatory networks are usually represented as graphs where nodes represent 
different genes and edges, which are typically directed, represent the potential effects of one 
gene on the other. The edges can hold more specific information about such interactions and 
their types in more complex types of networks. 
The construction of such regulatory networks has always been a challenge. Depending on 
the type and quality of the data used for such construction, the liability, size, and type of the 
reconstructed networks vary. Some methods are based on expression data as an input and 
try to predict the effects of genes on each other based solely on the variation of expression 
levels across different conditions or time points. Other methods use ChIP-seq data and other 
experimental inputs that are based on detecting regions of DNA bound by certain TF 
proteins. More complex methods evolved, combining several approaches and data inputs to 
generate more robust networks that could aid later in experimental design, decisions, and 
conclusions. What follows in this section is an overview of some of the main approaches for 
the construction of GRNs. 
 
 
Boolean networks provide a basis for one of the simplest methods for deriving GRNs. Using 
a threshold-based discretization, gene expression levels are presented in terms of two states, 
1 for expressed and 0 for non-expressed [3]. It then attempts to find Boolean functions for 
every gene in the network. However, this classical method suffers from information loss due 
to the harsh discretization and the threshold choice. Certain methods such as Reverse 
Engineering algorithm (REVEAL) extend this classic approach by adding the in-degree value 
of genes and utilizes mutual information but suffer from extensive computational time, thus 
suitable for analyzing a smaller set of genes [4]. Other methods that are based on the same 
principle have been developed, such as probabilistic Boolean networks, although improve 
on the original model still suffers from some of the inherited disadvantages [5]. 
 
Bayesian networks (BNs), which effectively represent probabilistic relations between 
variables, are popular models for deriving GRNs [6]. Despite its efficiency in dealing with 
noisy data, the  classical BN model cannot deal particularly with time-series data and 
feedback regulations, nor do they take into consideration the time lagging that usually occur 




that allowed them to handle time-series data, as well as hidden variables and missing data 
points effectively at the expense of computational time [7]. Versions of DBNs were developed 
depending excessively on prior knowledge, particularly information about transcriptional 
regulation to increase prediction accuracy [8].  
 
Differential equations were also an intuitive base for several GRN models. Ordinary 
differential equations (ODEs) can effectively model feedback loops and show good accuracy, 
especially in small scale networks. However, besides its expensive computational time, it is 
hard to describe the non-additive logic of gene regulation in ODEs. The difference equations 
model, unlike ODEs, uses discrete variables, which leads to information loss, but gives it the 
edge when it comes to dealing with time-series data  [9]. 
 
Association networks are undirected graphs that are used to describe GRNs.  It draws an 
edge between two genes that are, for example, co-expressed, without indicating which is 
regulating the other. ARACNE uses mutual information in combination with information   
about TFs and their binding sites to infer GRNS [10].  Graphical Gaussian models (GGMs)  
attempt to infer large GRNs using partial correlation [11]. 
 
Dynamic Regulatory Events Miner (DREM) attempts to reconstruct dynamic regulatory 
networks from time series expression data and protein-DNA interaction data. DREM uses a 
Hidden Markov Model (HMM) and identifies the genes associated with each bifurcation point 
[12]. A more elaborate version, iDREM, was developed to visually represent the bifurcation 
points and integrates several other sources [13]. However, this method still suffers from the 
significant difference between the size of the gene set and the number of time points and has 
an excessive computational time. 
 
Collateral-Fuzzy Gene Regulatory Network Reconstruction (CF-GeNe) uses a fuzzy c-means 
clustering algorithm to construct GRNs, which allows it to deal with noisy and missing data 
[14]. Other models such as Finite State linear model [15], State-space model [16],  and many 
other approaches and methods emerged and been used for particular cases successfully and 
unsuccessfully in the past years, and many other will continue to be developed and optimized 







3.2 Binding Site Analysis 
A Position weight matrix (PWM) is a model representation of a pattern or profile. While a 
PWM can be used to represent different types of profiles, in this manuscript, we refer to the 
PWMs that represent the binding profiles of TFs. A PWM summarizes the frequency by which 
a specific nucleotide appears at a particular position in the profile. It is extracted from the 
alignment of TF binding sites sequences, identified by techniques like DNase-seq and ChIP-
seqs, and the occurrence of each nucleotide at each position is counted and summarized in a 
matrix. This matrix can be visualized, for example using a logo plot.  PWMs are later used as 
an indicator to evaluate the likelihood of a particular transcription factor to bind to a specific 
segment of DNA, thus used via different algorithms to predict potential binding sites along 






Figure 9. A workflow that illustrates the typical steps for binding site predictions from deriving 






3.3  Gene Expression Analysis 
 
Owing to their decreasing prices, methods like RNA-seq and microarrays have generated and 
keep generating thousands of gene expression datasets. These high throughput technologies 
allowed the parallel analysis of tens of thousands of genes and their transcripts with a single 
experiment. Among these sets, I developed a particular interest in time-series datasets. Gene 
expression time series experiments provide insight into the molecular biology processes 
inside an organism over time. Time series experiments attempt to study the variation in 
transcription after stress such as starvation or a drug application or on the gene activation 
through an evolving process such as differentiation or organ development as in most of the 
cases covered in this thesis. The result of such experiments is typically a series of snapshots 
of the gene expression at different consecutive time points are obtained, compiled, 
formatted, and normalized accordingly. Such datasets not only provide a glimpse of the gene 
expression in a cell or group of cells but also shows the dynamics of such expression and its 
change across time, providing more information to capture than the static sets.  
 
With gene expression data sets, scientists face the challenge of having to analyze in parallel 
thousands of genes with usually only a few conditions or time points and sometimes no 
replicates. The experiment if not well designed, can add the problem of under-sampling 
where a lot of key information is missed, and the accuracy of the results is affected. Another 
challenge is in the biological variability between individuals and even cells of the same 
individual, which might be in a different cell-cycle stage. In the process of collecting the cells 
and preparing them for a process such as RNA-seq, these cells are actually destroyed and the 
data for the next time point or condition is taken from different cells where the variability 
mentioned before might arise. 
 
Despite these challenges, different methods were developed to analyze temporal expression 
datasets. These methods vary vastly in their approach and objective, answering different 
questions and generating different types of results. The following paragraphs attempt to 
summarize some of the common methods and tools that are used for identifying 
Differentially Expressed Genes (DEGs), detecting gene clusters and other various approaches 
usually applied to analyze gene expression data. 
To identify DEGs between two gene expression time courses, a method that uses the maximal 
difference of the area between the linear or spline interpolated gene expression 
measurements across time was proposed. 
 
A number of methods generate a gene ranking based on differential expression across time. 




differential expression within one or between two or more gene expression temporal 
datasets [18]. An approach by Kalaitzis et al. ranks differentially expressed genes using a 
likelihood ratio quotient or a Bayes factor after modeling gene trajectories by Gaussian 
process regression [19]. Mean Absolute Rank Difference (MARD) constructs gene 
relationship networks for the control and treatment time courses, measures the differences 
in the neighbourhood of each gene between the two networks, eventually identifying DEGs 
based on the significant changes in their estimated neighbourhood [20]. 
 
Other methods directly model the gene expression under various conditions and 
experimental designs directly on the discrete sampled time series.  An example of that would 
be the regression-based statistical modeling used in combination with permutation tests to 
find significantly differentially expressed genes [21]. Limma attempts to fit linear models to 
the gene expression values and uses moderated tests in the analysis of variance (ANOVA) 
framework to assign significance to its findings [22][23]. ANOVA models were also applied 
in combination with F– or permutation tests to identify significant time-group-interactions 
or the effects of experimental groups [24]. In order to remove the variance caused by 
individual differences, a modified repeated measure of  ANOVA was proposed [25] . The idea 
of utilizing a principal component analysis (PCA) for a dimension reduction of the estimated 
parameters from an ANOVA model in multiple series time course experiments was also 
suggested and applied [26].  
 
Alternatively some tools use Hidden Markov models (HMM) for identifying DEGs in gene 
expression time-course experiments. Non-homogeneous HMMs are to classify genes 
between the two states equally expressed and differentially expressed at each time point 
[27]. Hidden spatial-temporal Markov random fields are used to identify genes, which are 
differentially expressed at each time point in the context of known biological pathways [28].  
 
Other approaches model the measured gene expression trajectory as a continuous function 
in time. Gene-wise hypotheses testing can be used on the integral of the quadratic difference 
between the B-spline curves of two aligned gene expression time-series experiments [29]. 
Extraction of Differential Gene Expression (EDGE) Identifies differentially expressed genes 
via a procedure that fits a natural cubic spline representation of the gene expression 
trajectory under the alternative hypothesis and a constant mean curve under the null 
hypothesis. Permutation testing based on the residual sums of squares of both models 
assigns significance to the detected differentially expressed genes [30]. A functional 
hierarchical model that uses basis expansion to model gene expression trajectories was 
utilized by Hong and Li to identify temporally differentially expressed (TDE) genes [31]. 
Bayesian Analysis of Time Series (BATS) is a popular tool that analyzes one-sample time 
series [30] [31]. The functional Bayesian approach expands the gene temporal profiles over 




Bayes factors. A functional ANOVA mixed-effects model can be used to identify either non-
parallel differentially expressed genes or parallel differentially expressed genes [34]. A 
functional principal component analysis can also be used to test for changes in the temporal 
gene expression under different conditions [35].  
 
Different Clustering algorithms are typically applied to identify modules of co-expressed 
genes that have similar expression patterns over time. The common hypothesis behind these 
clustering approaches is that the genes that are expressed in a similar manner across time 
are likely to be co-regulated by a set of common regulators and/or are involved in the same 
biological process or functions. The clustering methods can be divided into three main fields, 
the similarity-based approaches, the model-based procedures, and template-based methods, 
which attempt to recognize genes with a gene expression time profile similar to predefined 
patterns. 
Weighted correlation network analysis (WGCNA) is a clustering method that uses a modified 
Pearson correlation coefficient to detect gene modules. WGCNA was implemented a popular 
R software package that includes a collection of other functions for constructing networks,  
topological analysis, and visualization [36]. 
Some clustering algorithms need a predetermined total number of clusters as in the case of 
the k-means procedure [37] or in the self-organizing map (SOM) framework [38].  In order 
to group genes with unknown function to clusters with a priori known function Brown and 
Grundy supervised a learning algorithm based on support vector machines (SVMs) [39]. 
CLICK is an algorithm that identifies homogeneous gene expression clusters based on graph-
theoretical and statistical techniques [40]. First and second-order differences between 
adjacent time points can also be used to evaluate the similarity and cluster genes accordingly 
[41]. Gene Shaving is an algorithm that applies sequential PCA techniques to identify those 
genes, which are largely varying across time and coherent to each other at the same time 
[42]. Clustering can also be based on a rank order-preserving matrix framework or by 
identifying minimum mean squared residue clusters [43]. TimeClust is a tool that 
implements different clustering techniques like Bayesian clustering [44].  
On the other hand, other approaches cluster genes by model fitting their expression 
trajectory in time, and/or applying a specific clustering model. A corrupted clique graph 
model can be used efficiently for the non-hierarchical clustering of genes [45]. An algorithm 
that  attempts to fit a mixture of multivariate Gaussian distributions to the gene expression 
values can be found in the popular package MCLUST [46]. Genes can also be clustered based 
on their involvement in a specific biological process based on a biological kinetic model [47]. 
Expectation Maximization (EM) is an algorithm that is used to cluster genes on the basis of 
their cubic spline representation in a predefined number of sets [48]. Cluster analysis of gene 
expression dynamics (CAGED) is a pseudo-Bayesian agglomerative clustering approach 
applied on auto-regressive gene expression models [49]. A similar approach based on 




Bayesian hierarchical mixture model was also published [50]. The EM algorithm can be used 
to fit a mixed-effects model on the B-spline representations of the gene expression profiles 
[51] or for modeling a mixture of simplified differential equations in order to cluster genes 
according to their temporal expression [21]. Clusters can also be identified using the EM 
algorithm to fit mixtures of linear models or linear mixed models [52] . A rejection-controlled 
EM algorithm is used in a mixture of mixed-effects models, in order to estimate the class 
assignment and the corresponding mean expression curves is used [32]. Another model was 
developed based on clustering linear HMMs, and the Graphical Query Language (GQL) [53]. 
An approach for the analysis of gene expression time series infer gene clusters from finite 
mixtures of HMMs while using prior information in a semi-supervised learning framework 
was also proposed [54]. Microarray Significant Profiles (MaSigPro) identifies gene clusters 
of differentially expressed genes by a two-step regression approach, where the algorithm is 
based on the similarity of the gene-wise regression model coefficients [55]. A Bayesian 
hierarchical clustering of nonlinear regression spline representation of the temporal 
trajectories was also proposed [56]. 
 
Some clustering approaches attempt to identify statistically significant patterns of 
expression in the data, and the genes associated with them, based on permutation or 
resampling procedures. EPIG is a method that uses a multi-step filtering procedure to 
generate representative candidate patterns from the gene expression data [57]. An order-
restricted inference methodology defining candidate temporal profiles in terms of 
inequalities among the mean expression levels at the time points was proposed [58].The 
ORICC algorithm groups the gene trajectories according to an order-restricted information 
criterion to pre-specified candidate inequality profiles [59]. StepMiner aims to detect genes 
with one or more binary transitions across the gene expression time series by modeling 
segment-wise constant adaptive regression [60]. GOALIE  uses linear time logics to identify 
spans in the time series and separate gene clusters with similar gene expression patterns in 
these spans [61]. Short Time-series Expression Miner (STEM) matches the gene expression 
profiles on data-independent, chosen model profiles and applies a time point permutation 
test to assign significance to the corresponding gene clusters [62]; afterwards, a Fisher test 
is used to identify GO gene sets enriched with genes from significant clusters. Springer et al. 
proposed a data-driven selection of model profiles, which gains a better fit to the data 
structure, but with the drawback of losing the significance assessment for the identified 









Some methods have a different approach for analysing gene expression data compared to 
the previously described DEG and clustering methods. In order to generate hypotheses about 
the function of genes not yet annotated to any predefined GO gene set, Hvidsten et al. used a 
systematic supervised learning approach based on learning a classification rule model 
within the rough set framework and then evaluating it by cross validation [64]. A unified 
mixed effects model is constructed for the mean trajectory of every gene set to capture  those 
sets where 20 – 50 % of the genes follow the same trend [65]. On the other hand the more 
elaborate GlobalANCOVA fits a linear model to the gene expression value for every gene set 
and identifies those groups, in which a design factor such as treatment-time interaction, is 
significant in contrast to a reduced model [66]. A nonparametric Wald-type test statistic is 
also used in combination with a permutation-based test to detect treatment effects or 
treatment-time interactions in predefined sets of genes [67]. Principal components Analysis 
through Conditional Expectation (PACE) proved effective in estimating the mean trajectory 
function for sparse longitudinal data [68]. MaSigFun fits regression models to the gene set 
expression values in the time series assuming that all group genes follow the same 
underlying trajectory. PCA-maSigFun is a version of the latter method where more than one 
model profile per group is allowed [69]. 
 
A general drawback of most of the computational methods described in this section is that 
they very often have to deal with large data sets, listing hundreds of genes, making it hard 
for the biologists to go through each manually and renders the results too general and broad 
to be conclusive. Another drawback is the typical black box, where the biologists find it hard 
to understand exactly how the results where computationally produced, thus less confidence 
in using the results for the next experimental validation. As most computational approaches 
develop black-box algorithms, there is a demand for developing ready to use interactive 
visual tools. Experimentalists could use these tools to explore dynamically and track 
different genes and other aspects of gene regulation which can involve their biological 
intuition and deep understanding of the experimental context which is usually and 





3.4 Network Visualization 
 
Figure 10. A classic hairball view representing the problem of visualizing large networks. 
Humans are visual creatures whose brains have evolved to recognize and classify visual 
patterns. Looking at a network representation as an edge list or an adjacency matrix might 
be easy for a computer program but can prove useless for the human brain. On the other 
hand, representing a network as a visual graph is intuitive when it comes to the human eye. 
Thus, since the early days of bioinformatics, biological networks have been displayed and 
drawn as simple basic graphs. But this worked until the complexity and size of such networks 
increased, where the simple method leads to what is described in visualization as the hairball 
problem. Networks with thousands of nodes and millions of edges, when presented as a 
graph, can give little information besides a general view on the topology of such a network 
(Figure 10). Several solutions have been developed to be able to make sense visually of such 
networks. One common approach is clustering nodes into modules that are highly connected 
internally and loosely connected to each other, providing a summary of the different 
components of the network. This clustering can be based on different features such as 




Cytoscape is one the most popular network visualization tools in the bioinformatics 
community. Cytoscape is a software that provides a framework where different visualization 
apps can be integrated [70]. Cytoscape includes a large number of apps and is continuously 
expanding due to the contributors in the Cytoscape community [71]. Since this thesis is 
highly based on time series data, those apps that can integrate temporal expression data and 
visualize dynamic networks are of main focus. Some apps stand out in Cytoscape as being 
able to deal with dynamic networks. DyNet is a plugin that compares two or more networks 
to identify the most 'rewired' nodes [72]. CyDataSeries allows the user to enrich networks 
with data series such as gene expression measurements across multiple time points or 
conditions and supports some basic manipulation with the data series [73]. DynNetwork is 
a plugin for importing, visualizing, and analyzing dynamic networks in Cytoscape. The 
dynamics of nodes, edges, attributes can be visualized at the desired time points. To improve 
visualization, the nodes can be animated with a dynamic force layout algorithm. Some other 
approaches require that the user enters the precomputed dynamic network in the form of 
successive networks and then visualizes each of them separately in consecutive snapshots. 
This leads to a problem where the nodes change places making it hard to track a particular 
node through the different time points. 
Most of the bioinformatics visual apps and software have to be locally installed and mostly 
require importing a resulting network from another pipeline. This aspect discourages and 
intimidates non-bioinformaticians from exploring the possibilities and potential of such 
tools. Hence, one of the goals of the developed workflow is to have it implemented also in a 
webtool making it simple to used requiring merely few clicks and no programming 
prerequisites thus reaching for a wider audience. Another problem I wanted to avoid is 
presenting networks that are too big to be analyzed visually. Thus, I focused on finding a way 
















RNA-seq is one of the popular methods for quantifying gene expression. An RNA-seq 
experiment starts with isolating the RNA material from the sample under study, then 
generating a cDNA complementary fragment for each RNA fragment. Afterwards, the RNA is 
washed out, leaving the cDNA to be sequenced and mapped to the genome. The result is a 
quantification of these transcripts, which is transformed to gene expression levels. RNA-Seq 
typically costs more than a microarray experiment but the added benefits outway the 
additional costs most of the time. As the prices of RNA-Seq decrease rapidly, its utilization in 
experiments increases and an expanding resource of RNA-Seq based gene expression data is 
available. 
4.2 ChIP-seq 
ChIP-seq is a method used to determine where specific proteins, like transcription factors, 
structural proteins, and protein modifications, bind to the DNA. Chip-Seq uses chromatin 
immunoprecipitation (ChIP) followed by sequencing through the following steps (Figure 11): 
Step 1: Cross-link the protein to be studied to DNA. 
Step 2: Destroy the cell and shred the DNA strands with the attached proteins into segments 
of hundreds of base pairs each using sonication.  
Step 3: Add bead-attached antibodies into the DNA segments. These antibodies will bind to 
the target protein and precipitate them along with the DNA segments that are connected to 
it. 
Step 4: Unlink the protein from the DNA strands. 
Step 5: Sequence the DNA segments. 






Figure 11. The ChIP-seq experimental workflow.  
. 
 
Eventually, Chip-Seq generates a list of target DNA binding sites for the TF under study. 
These sites are usually hundreds of base pairs long which decreases the accuracy of finding 
the exact actual active site where that protein binds within that region. However, different 








TRANSFAC® is the most comprehensive database that stores information which revolves 
around transcriptional regulation in eukaryotes [74]. TRANSFAC® is manually curated, 
maintained, and available from GeneXplain at http://genexplain.com. It stores millions of 
experimentally verified DNA binding sites along with with details such as the exact position 
in the genome, the experimental method used and the DNA sequence corresponding to the 
site. The binding sites are aligned in order to construct a comprehensive library of thousands 
of PWMs. This PWM library provides a good quality resource for the different workflows 
available at GeneXplain (Figure 12). 
 
 




4.4 MATCH™  
MATCH™ is a tool for predicting potential binding sites of TFs in a given  DNA sequence based 
on a PWM library [75].   Although other tools have been developed for identifying potential 
TFBS, the power of this tool stems from its usage of the TRANSFAC® library of matrices, built-






















two scores to evaluate how similar a sequence of nucleotides is to the matrix under search. 
These scores are: 
 
1. MSS or matrix similarity score, calculated using the following formula:  
 
=
−   
−  
 
Where:     
 = ∑ ( ) f  i, bi 
 f i,B  : frequency of nucleotide B to occur in position i of the matrix.     
 = ∑ ( ) f min i, bi 
 f i,B : lowest frequency in position i of the matrix. 
 = ∑ ( ) f max i, bi 
 f i,B  : highest frequency in position i of the matrix. 
 I(i)= ∑ i,B  ln(4 f i,B) ,  i=1,2,..L 
 
2. CSS or core similarity score: is calculated similarly to MSS but using the core positions 
only ie. the first five most conserved consecutive positions of a matrix. 
 
The lowest score 0.0 corresponds to the state where Current=Max meaning every base in 
the sequence matches with the base with the lowest score in that position in the matrix. 
The highest score 1.0 is obtained in the state where every matching nucleotide matches with 
the base with the highest frequency in the matrix. 
A cutoff for each of following metrics is either automatically set by the program or can be set 
by the user, and only the matches that have both scores higher than the thresholds are 
included in the result.  Depending on his objective a user can choose one the precalculated 
cutoffs for each matrix which are: 
a) minFN : Cut-offs minimizing false negatives. 
b) minFP : Cut-offs minimizing false positives. 
c) minSum : Cut-offs minimizing the sum of both false negative and false positive rates. 
The tool is available publicly at: 
 http://www.gene-regulation.com/pub/programs.html#match 
 http://compel.bionet.nsc.ru/Match/Match.html 
 http://www.biobase.de : A more advanced version Match™ Professional, allows the 






TFClass is a resource that provides a classification of eukaryotic transcription factors based 
on their DNA-binding domains (DBDs). It comprises six levels: 
1. Superclass: Based on the similarity in the general DBD topology.  
2. Class: Based on the similarity in the structure of the DBD. 
3. Family: Based on the similarity in the sequence and function. 
4. Subfamily: A subgrouping based on the similarity in the sequence (Optional).  
5. Genus: The TF gene. 




Figure 13. A snapshot from the TFClass web interface showing a part of the hierarchical 
classification tree (Source : http://tfclass.bioinf.med.uni-goettingen.de , 05.11.2019) 
 
 
TFClass can be accessed via a web interface where the user can search for a particular TF 
or label or explore the ontology (Figure 13). Along with with the classification a more 
detailed view that contains particular information about the item clicked such as the 




information for the different levels. The detailed view contains also links to online 
resources such as Ensemble and UniProt which can be practical for further exploration and 
investigation. 
TFClass is publicly available at http://tfclass.bioinf.med.uni-goettingen.de/. 
 
4.6 PC-TraFF 
Potentially Collaborating Transcription Factor Finder (PC-TraFF), is an algorithm for 
identifying potentially collaborating TF pairs based on their binding sites distribution and 
relative distance in the genomic regions of interest [76] . PC-TraFF is implemented in the 
form of a user-friendly web service that takes a set of genes or alternatively a set of 
sequences, and a number of parameters such the minimal and maximal distance between to 
TFBSs, number base pairs upstream from a gene to look for TFBS pairs, and a Z-Score 
threshold. As a result, the algorithm generates a table of significant TFBS pairs which can be 
later associated with certain TFs (Table 1). The web service also offers the option of viewing 
the results as an interactive network that links the collaborating pairs to each other through 
edges and clusters the network via a Markov clustering algorithm. PC-TraFF is freely 
accessible at http://pctraff.bioinf.med.uni-goettingen.de/. 
 
Table 1. A sample tabular output from PC-TraFF . Potential collaborating TFBS pairs along 
with their Z-Score and references that support the prediction 
Pairs Z-Score Reference 
V$EGR_Q6 - V$SP1_Q2_01  6.19841 BioGRID 
V$CETS1P54_01 - V$SP1_Q2_01  5.77081 TRANSCompel 
V$MYCMAX_B - V$SP1_Q2_01   5.26869 BioGRID 
V$AP1_Q2_01 - V$AP1_Q4_01  4.85265 TRANSCompel, BioGRID 
V$CEBP_Q2 - V$STAT6_01  4.71775 TRANSCompel, BioGRID 
V$CETS1P54_01 - V$EGR_Q6  4.69386  




V$CETS1P54_01 - V$PEBP_Q6  4.57839 BioGRID 








Figure 14. A visual representation of the collaborating TFBS pairs in the form of an interactive 
network generated by the web-interface of PC-TraFF. The blue edges denote interactions 
between TFs whose importance is experimentally verified whereas red edges indicate potential 
interactions between transcription factors that have not been experimentally validated yet. 





4.7 Network Construction 
A library of position weight matrices (PWMs) from TRANSFACTM  [74]version 2013.1 was 
used in combination with the MATCHTM [75] program to predict binding sites of transcription 
factors in the conserved promoter regions of the human genome as described in a previous 
publication [77] (Fig 1D). The promoter region was defined as 1000 base pairs upstream 
from the RefSeq-defined TSS of the gene. The conservation is based on the alignment 
between the human, mouse, dog, and cow genomes.  As a cutoff, the top 5% of the binding 
site predictions for each matrix, ranked according to the MATCH score, were considered.  
 
The results were stored in the form of the regulatory network were the TFs and their target 
genes are represented as nodes, and a directed edge is drawn from the TF to the target gene 
if the TF has a potential binding site in the promoter of the target. The core network included 
829 TFs and their 16354 targets summing up to 749949 interactions.  Another expanded for 
of the network, which contains additional microRNA binding predictions based on mirTrans 
[78], was constructed and contained 2239 regulators and 20160 targets.  This network was 
computed once and is independent in the process of its derivation from the expression data, 
Figure 15. Constructing the regulatory background network. Applying MATCHTM, which 
utilizes a TRANSFAC® PWM library, to conserved promoter regions ended up with a network 




making it usable with every human expression dataset (Fig 1E). The conservation property 
of these sites makes the prediction ideal for the differentiation context since several pieces 
of research have shown that conserved regions in the DNA are critical binding sites for 





Neo4j is an open-source graph database engine that is considered one of the leading engines 
in its domain[83]. 
In this project, Neo4j was chosen as an environment to implement the graph database for 
the following reasons: 
 It is an open-source software 
 It uses native graph storage optimized for fast traversals. 
 It has a simple core java API that can manipulate the finest details in the database 
 It has APIs built for several languages including Python PHP, R, Perl, Ruby, NET and 
many other plugins that are being added with time. 
 It provides very clear documentation and active discussion forums. 
 It is very scalable (up to billions of nodes/relations), which is very convenient for 
growing data. 
 It has built-in common graph algorithms already implemented and very flexible for 
direct usage  
 It has a built-in visualizer that is customizable, user-friendly and directly linked to the 
database. 
 It has a built-in web interface in which the database can be accessed and queried 
remotely with security controls. 
 
Through this project, the Neo4j 2.1.2 community version was installed, and the 
corresponding Neo4j java library was used in the java implementations of the database. 





4.9 Gene Ontology 
 
 
Gene Ontology (GO) is a knowledge base that stores information about the biological role of 
genes and their products on different levels. It is a popular, reliable, widely accepted 
resource that has been cited thousands of times in the scientific literature[82] [83] . 
 
 Its backbone is an ontological structure that stores terms of biological functions terms and 
defines their relationships with each other.  The main types of relationships are: 
 "is a": when term X is a term Y, it indicates that X is a subtype of Y. 
 "part of": when X is a part of Y, it indicates that the presence of the X implies the 
presence of Y, but the opposite is not necessarily true. 
 "has part": when X has Y as a part, it means that X necessarily has part Y. If X exists, Y 
will always exist; however, if Y exists, we cannot say for certain that X exists.  
 "regulates": Indicates the ability of a specific process or term to regulate another. 
 
The second component is the GO annotations. Through these annotations, genes and their 
products are associated with terms in the ontology. This summarizes the different known 
biological roles of a gene in different contexts. The annotations are based on evidence from 
literature and different curated databases. 
To evaluate the relevance of the gene sets at each stage, a GO enrichment analysis using the 
biological processes and a Fisher's Exact test on each column in these cascades was applied 
using one set at a time as an input. Terms that had a p-value less than 0.05 after the 
Bonferroni correction were sorted by their fold enrichment and the top terms were 
examined (Table 2). These terms were evaluated based on their consistency with the stage 











Table 2.  An example of a Gene Ontology analysis result table. The terms are sorted here by fold 
enrichment and all have a p-value less than 0.05. 











ventricular cardiac muscle cell differentiation  18 3  .01 > 100 + 9.20E-04 
pharyngeal system development  26 3  .01 > 100 + 2.52E-03 
cell fate determination  42 3  .02 > 100 + 9.76E-03 
cardiac ventricle morphogenesis  72 3  .03 87.48 + 4.61E-02 
cardiocyte differentiation  116 4  .06 72.40 + 1.85E-03 
cardiac muscle tissue development  159 5  .08 66.03 + 5.96E-05 
cellular response to steroid hormone stimulus  187 4  .09 44.91 + 1.19E-02 
mesenchyme development  216 4  .10 38.88 + 2.09E-02 
striated muscle tissue development  285 5  .14 36.84 + 1.03E-03 
muscle tissue development  298 5  .14 35.23 + 1.28E-03 
heart morphogenesis  249 4  .12 33.73 + 3.65E-02 
regulation of animal organ morphogenesis  256 4  .12 32.81 + 4.06E-02 
gland development  417 5  .20 25.18 + 6.63E-03 
heart development  528 6  .25 23.86 + 4.52E-04 
chordate embryonic development  640 7  .30 22.96 + 2.52E-05 






Cytoscape.js is an open-source JavaScript library that specializes in graph analysis and 




which was created at the Donnelly Centre at the University of Toronto within the wider 
framework of Cytoscape [84][85]. 
Cytoscape.js allows the display and manipulation of graphs in desktop and mobile browsers. 
This library allows the user to interact with the graph and allows the client to hook into user 
events and includes basic to advanced features such as pinch-to-zoom, box selection, 
panning, and others. It also contains a collection of different layouts which is continuously 
growing and adapted for different uses and graph types.  
Aside from visualization, this library has various built-in graph analysis algorithms and 
functions such as the Breadthfirst algorithm, which can be easily used and built on for the 
development of more complex algorithms.  
 
We used Cytoscape.js as a bedrock upon which we extended and built the JavaScript 
visualizations in our web tool. New layouts, animations and features were built to suit our 
purposes and can be reused and extended in the future to branch into more complex web-
based network visualizations. 
 
4.11 Data 
4.11.1 The Heart Development Dataset 
The main project I worked on during my PhD period involved a collaboration with the 
Institute of Pharmacology and Toxicology in the University Medical Center Göttingen.  The 
project revolved around examining the process of differentiation of cardiomyocytes from 
human pluripotent stem cells (hPSCs) on the genetic level.  
The project was based on an experimental model that simulates human heart muscle 
development the generation of bioengineered heart muscle (BHM) directly from hPSCs. This 
experiment is the first detailed characterization of a novel cardiac organoid model, 
generated by a single step tissue engineering approach directly from hPSCs, with 
organotypic contractile functionality.  
The experiment revealed that BHMs indeed traverse through defined in-utero like 
developmental stages with characteristic transcriptome profiles, are composed of mainly 
mesodermal cells (cardiomyocytes and fibroblast-like cells), display continuous functional 
maturation over time with enhanced contractile performance on the cellular level and 
develop in late cultures (day 60) a functional neural crest component with resemblance to 
the cardiac sympathetic nervous system. A detailed characterization on the molecular, 
cellular and functional level of this model is described in the dissertation of F. Raad PhD, in 





HESC cultures of HES2 cell line were maintained on IR-HFF layers in HES medium. The HESCs 
were then cultured in basal medium and different factors were added to the medium as 
indicated in Figure 16. 
 
 
Figure 16. Different agents added at different time point through the experiment. 
 
At day -1 cells were passaged and plated. 24 hours later, cells were washed with basal 
medium before the start of the mesoderm induction phase (3 days); following growth factors 
were added to the basal medium for mesoderm induction: CHIR99021, FGF-2, BMP4, 
Activin-A. Culture medium was exchanged daily until day 3 . 
Subsequently, the cardiac specification was induced for 10 days with the addition of an 
inhibitor of Wnt production IWP4. 
Thereafter, cardiomyocytes were maintained in basal medium with medium exchanges 
every 2 days . The beating was observed starting day 13, and the cells were harvested on day 
22. The cells were afterwards rinsed and collected. 
The experiment was followed with a quantification using RNA-Seq which produced 
transcript counts of around 20,000 genes across eight different time point with four 
replicates each. The time points used were denoted as the following days: D_1 (control) , D0, 
D3, D8, D13, D22, D29, D60. The data also contained RNA-Seq counts for two time points in 
2D culture, however they were mostly irrelevant to the analysis which focused on the more 




resulting normalized set was used for the analysis. This dataset is referred to as the heart 
development  dataset throughout this manuscript. 
 
   
4.11.2 Other Sources 
 
The first secondary dataset, Dataset 2, was derived from the normalized expression datasets 
from the previously published study by Qing Liu et al [88], publicly available in the GEO 
repository under the accession number GSE85332.  The dataset covered the RNA-Seq 
profiling of the differentiation of four different stem cell lines into cardiomyocytes, 2 hiPSC 
lines (C15 and C20) and 2 hESC lines (H1 and H9). The gene expression for the genes in each 
cell line was taken at four stages:  pluripotent stem cells (day 0), mesoderm (day 2), cardiac 
mesoderm (day 4), and differentiated cardiomyocytes (day 30).  The assembled and 
formatted data can be found in S2 Dataset. 
 
Dataset3 was assembled using public RNA-Seq data that is captured during the 
differentiation of H1 derived human neuronal precursor cells (NPCs) across the days 
0,1,2,4,5,11, and 18 after induction of neuronal differentiation.  Publicly available DEGs and 
GO enrichment analysis on the same dataset was used for comparison.  The dataset and the 
analysis results could be found in the expression Atlas under the accession E-GEOD-56785.  
The assembled and formatted data can be found in S1 Dataset. 
 
Dataset4 was based on the temporal profiling of HIV SupT1 CD4+ T cells detailed in a 
manuscript published by Golumbeanu et al. [89]. The cells were either Mock-infected or 
infected with an HIV-GFP-based vector. The expression of the genes was profiled at five time 
points of the viral replication process. The data is publicly available from NCBI’s Gene 












This section represents the various results of my PhD work, from the methods developed, to 
their implementation, their application to real life datasets, and the biological conclusions 
and implications of the outputs. 
In the first subsection, I describe the work  I have done on enhancing the existing regulatory 
network previously published by M. Haubrock [90], by adding additional relevant sources, 
which resulted in different networks that can be used according to the context. Furthermore, 
in this subsection, I describe the strategy I used to store the resulting networks in a fitting 
database structure to facilitate its usage in the next parts of the work.  
The central and novel part of the results comes in the following part of the results. In the 
second subsection, I introduce the concept of the TRC model, the computational and 
mathematical model behind, and the detailed steps of the TRC workflow. 
Afterwards, in the third subsection, I introduce the web service, which I developed 
throughout my doctoral studies, which is an implementation of the TRC workflow as well as 
other workflows that cover aspects such as co-expression and co-regulation.  
Subsequently, the application of the theoretical concepts and the tools developed on 
different experimental datasets will be described. The detailed, in-depth analysis of the heart 
development dataset is covered in the fourth subsection using the TRC model and the 
accompanying workflows. 
The final subsections cover the analysis of other datasets, however, in varying details 
depending on the dataset. The work is entirely reproducible using the webserver, the 







5.1 Background Regulatory Network 
Different contexts require different background regulatory networks depending on the 
questions the scientist is trying to answer. For that purpose, I attempted to enhance and 
expand the regulatory network developed by M.Haubrock [90], adapting it to be suitable as 
a backbone for the different workflows and tools I constructed.  
As the binding site predictions are the backbone of the regulatory network, the match scores 
of these predictions can be a good measure of the quality of the network. For each PWM, 
these predictions are ranked based on the match score, and the top n predictions are 
considered to derive what Haubrock refers to as an n-prf network. The 1-prf network is the 
smallest and is based only on predictions that belong to the highest top 1 percent, and the 
100-prf network is the largest, based on all the predictions that satisfy certain thresholds 
and cutoffs that are detailed in Haubrock’s work. In the work that follows, whenever not 
specified, we refer by default to the 5-prf regulatory network as a background regulatory 
network. 
 
5.1.1 Network Enhancement 
 
We wanted to integrate additional resources to the network to enhance the information 
content, check for experimentally verified regulatory predictions, and evaluate the overall 
predictive quality of the background regulatory network.  
As a first step, we attempted to integrate all the available ChIP-seq data resulting from 
experiments done on human cells in different tissues and contexts, which are stored in the 
ENCODE project [2][3]. We chose to integrate the data into the 100-prf network, thus 
covering all the possible predictions, allowing us additionally to study whether a higher 
match score corresponds to a higher probability of having experimental validation. For this 
integration to happen, we had to align all the predicted binding sites with all the ChIP-seq 
fragments from all the experiments. For each binding site prediction corresponding to a 
PWM, we needed to search for all the ChIP-seq fragments where a TF that is associated with 
this PWM binds in the region where the site lies Figure 17. This task proved to be very 
expensive in terms of computational time, so we had to develop a system that facilitates this 








Figure 17. The prediction-ChIP overlap criteria. If a binding site prediction p overlaps with a 
ChIP-seq segment c, where p.start>c.start and p.end<c.end, and the TF in that ChIP-seq 
experiment is associated with the PWM upon which this prediction is based, then this prediction 
is considered to be experimentally validated. 
 
For that purpose, we developed an overlap system we call the Parallel Tables System (PTS). 
The PTS takes advantage of the fact that the predictions and ChIP-seq fragments are both 
based on the same version of the human genome, hg19.  That means if we divide the genome 
into smaller regions, we only need to compare the predictions in this region with the ChIP-
seq fragments in the same corresponding region, rather than comparing them with every 
ChIP-seq fragment Figure 18. This system was to speed up overlapping between predictions 
and experimental data by spreading the data on several smaller tables.  This reduced the 
complexity significantly and allowed the overlap to happen in a feasible time frame. The 
criterion of spreading these tables was to be chosen carefully to minimize as possible the 
number of comparisons and mismatches. These tables should fit into the main memory easily 
and at the same time, be independent of the rest of the tables in the group so that during the 
joining process, each table is loaded and used once. The PTS system can be proven 
mathematically to cover all the overlaps needed without any information loss. The 
complexity of such a system is far lower due to the reduced number of comparisons to be 






Figure 18. Spreading the ChIP-seq and the predicted binding sites tables using the PTS. The 
genome is divided into slightly overlapping regions of 3000000 bp, and a table is dedicated to 
each region for both the ChIP-seq and the predictions that fall into that region. Each prediction 
table is joined with the corresponding table from the ChIP-seq tables. The join results are then 
collected and summarized in one result. In this particular configuration, the PTS was 1050 
times faster than a regular table join. 
Not only that, but we found that the same system can be reused for solving any similar 
genomic overlap problem, such as overlapping ATAC-Seq, DNase-Seq, and other data sources 






Figure 19. A comparison between the average scores of the ChIP-verified predictions and the 
non-ChIP-verified prediction for some of the matrices in the study. The ChIP verified predictions 
turned out to have a higher match score on average for most of the matrices, confirming the 
relevance of the match score in the likelihood of the prediction to be true.  
After overlapping the ChIP-seq experiments with the predictions, we performed a study that 
compared the average match score of the binding sites with experimental validation vs. those 
that had no ChIP-seq experiment supporting them. This was done for each of the PWMs 
separately, studying the set of the binding sites associated with each PWM. The associated 
binding sites set for the PWM is separated into experimentally verified, those which 
overlapped with a ChIP-seq segment of an experiment that used a TF associated with this 
PWM, and those which did not overlap with any. For 98% of the PWMs, the experimentally 
verified binding sites set had a higher average match score than the non-experimentally 
verified Figure 19. This showed the importance of the match score in determining the 
likelihood that the binding site prediction is used in a biological context, and gave us a reason 
to use the regulatory networks with lower prfs, such as the 1-prf and the 5-prf networks. 
5.1.2 Network Storage 
At first, binding site predictions or regulatory interactions were stored in an SQL database. 
However, the traditional relational database model is not well suited to store highly 
connected entities such as regulatory interactions, which are, in their essence, more of a 




based on graph theory, and algorithms as simple as finding the shortest regulatory path from 
one gene to the other were computationally expensive in such a tabular database structure. 
For that reason, we needed to upgrade the storage system from an SQL database to a NOSQL 
graph database. Neo4j was the engine and database system of choice for the many reasons 
mentioned in the materials and methods. Thus I designed two simple graph database 
structures, one designed to contain detailed information, mapping TF gene names to PWMs 
to binding sites in target genes, and the other summarizes all the information from the first 
in the form of regulatory interactions and integrates a summary the ChIP-seq experiments 
associated with each regulatory interaction. The two databases were used for different 
questions, depending on the level of detail and the type of query. The second database, which 
was structured as a regulatory network with direct regulatory interactions, provided the 
backbone for most of the work that follows. 
The first database was designed using three different kinds of nodes (Figure 20): 
1. Gene: a node where a gene is represented, and information such as its official symbol 
and name are stored as properties of the node. 
2. Matrix: a node where a matrix is represented and information such as its name and 
the associated PWM. 
3. Binding Site: a node where a binding site is stored and information such as the 
nucleotide sequence of the site,  the strand, and chromosome on which this site lays, 
its coordinates, and a boolean value that tells whether this site is verified through the 
ChIP-seq overlap previously described. 
These nodes were connected by three types of relationships: 
1. UsesMotif: connects a gene node with a matrix node associating a regulatory gene 
with the binding motifs that could be used to determine its binding site. 
2. Matches: connects a matrix node with a binding site node associating a motif with 
the binding site that was found based on its PWM. 
3. InPromoter: connects a binding site node with a gene node associating the binding 







The second database was designed using only one kind of nodes ( Figure 21): 
1. Gene: Similar to the previous database, it contains basic information such as the 
official symbol and the name of the gene. 
The second database contained one relationship type. However, this relationship contained 
properties that summarized some of the information contained in the previous database: 
1. Regulates: Connects two gene nodes associating a gene, a regulatory one,  with a 
target gene. If a gene has at least one directed connection in the first database with 
three hops: UsesMotif then Matches, then InPromoter to another gene to this 
relationship is represented in the second database via this single relationship. In  
other words, if a regulatory gene has a potential binding site in the promoter of 
another gene, then it is considered potentially regulating it, and they are connected 
by an edge in the second database. Four properties were stored in the relationship:  
 ChipNum: The number of ChIP-verified binding sites supporting this 
regulatory relationship. 
 ChipScore: The average score of the  ChIP-verified binding sites. 
Figure 20. The graph database schema used for the first database. Three types of nodes and 
three types of relationships were used to store the information previously stored in an SQL 





 NonChipNum: The number of binding sites related to this regulatory 
relationship that did not overlap with any ChIP-seq fragment. 







Figure 21. The graph database schema used for the second database. It uses only one type of 
node and one type of relationship, summarizing the essence of the information in the previous 
database. It allows the user to query regulatory interactions between genes and filter them 
based on experimental evidence. 
 
These databases can be accessed and used via the built-in Neo4j interface using the Cypher 
query language. For the integration of these databases in the workflows, a Neo4j Java API 





Figure 22. A snapshot of the Neo4j local web interface displaying a visual result of a Cypher 
query. Regulatory interactions between different genes are shown as well as the information 
contained in one of the “Regulates” relationships between two genes. The properties of the 
relationship indicate that there are 15 ChIP verified binding site predictions that support this 





5.2 Temporal Regulatory Cascades 
The Temporal Regulatory Cascade (TRC) model is a series of connected stage-specific 
regulatory networks that form a cascade-like architecture incorporating temporal order and 
gene expression as well as conserved TF binding sites information. The TRC is constructed 
via a workflow that has two main elements ( Figure 23): 
1. The background regulatory network, which was described previously, which 
provides an independent source of regulatory interactions and gives rise to the edges 
in the TRC. 
2. The temporal gene expression data, which varies depending on the experiment,  and 
provides the basis for identifying stage-specific regulatory and non-regulatory genes 
by detecting single peaks in their expression pattern. These stage-specific genes, 
typically regulatory genes, are represented as nodes in the TRC. 
 
 
Figure 23. The TRC workflow in a nutshell. Combining gene expression and binding site 





For simplicity purposes in explaining the methodologies that follow, we assume that the 
experiment is neither over or under-sampled thus the terms “stage” and “time point” might 
be used interchangeably, however it is worth defining the two terms as follows:  
 Stage: A stage where distinct biological events happen in the experimental context 
under study. A stage could be represented by one or multiple time points in the data 
set, or not represented at all in case no gene expression snapshot was taken through 
it. 
 
 Time point: A point represented typically by a column of expression values taken at 
a particular time in the course of the experiment. A time point might represent a 
biological stage or not, depending on the experimental design. 
 
5.2.1 Template Peak Patterns 
The TRC method utilizes the concept of constructing artificial template patterns of interest 
and attracting genes that behave similarly to these patterns using correlation. The template 
patterns used were stage-specific patterns, peaking at one time point each, and denoted by 
template peak patterns (TPPs). While different kinds of template patterns can be used, we 
chose the single peak TPPs as a default for its ability to attract stage-specific regulators that 
are unique to each time point.  
  = {  , … ,   }  denote the set of time points in an experiment and = {  , … ,   } 






   denote the expression data matrix where   is the expression  
of  at time point j. 
 
 ( , ) denote the regulatory network graph. With N denoting the set of nodes and E 






A Template Peak Pattern or TPP (    in the previous defenition) associated to 
time point t (Figure 24) is an expression pattern constructed such that the expression is: 
-  100   at time point t. 





For simplicity purposes in explaining the model and the workflow, we are assuming the data 
has one replicate per time point. However, when replicates exist for each time point in real 
datasets, we apply for each replicate what applies for the time point. For example, In the case 
where the time point has several replicates associated with it, as it often is, the peak spans 
through all the replicates. Becoming as follows: 
Definition 1:   = { ,  … ,   } a library of artificial template peaking gene 
expression patterns where: 
                    = { …  :    = 0       ≠         = 100     =  } 
Figure 24. The TPP associated with time point T2. The pattern shows a maximal 





An Artificial Peak Pattern or TPP associated to time point t (Figure 25) is an expression pattern 
constructed such that the expression is: 
 -  100   at every replicate of time point t. 




Figure 25. The TPP of T2 with multiple replicates per time point. The same principle as the 
















































Figure 26. A library of TPPs (     ℎ   ) based on an 8-Time 





5.2.2 Identifying Stage-Specific Regulators 
 
 
After a TPP library is constructed, a set of stage-specific regulators is constructed for each 
time point based on the TPP associated with that time point. 
 
The correlation between each TPP and the expression pattern of every regulatory gene the 
gene set is calculated. Genes that have a high correlation above a certain threshold, with the 
TPP of a time point, form the initial stage-specific regulatory set associated with that time 
point (Figure 27). Although it is not obligatory to use regulatory genes, it is a default to restrict 
the TRC analysis to regulatory genes as they provide a good starting point for different 
analysis, contribute to a larger set of regulatory interactions, and keep the TRC concise as 
the number of the non-regulatory genes is at least 20 fold larger. Unless otherwise specified, 
the TRC corresponds to a regulatory-genes-only TRC. Each stage-specific regulatory set is 
later trimmed based on size parameter maxS, and only the highest correlated genes to the 
TPP are taken in the TRC. 
 
Figure 27. (Left) The TPP of T2. (Right) The top 10 correlated regulators to that TPP and their 
expression patterns. One can clearly observe the peaks in their expression at T2.  




Definition 2:  = { ,  … ,   } a sequence of gene sets where:   




5.2.3 Mapping Regulatory Interactions 
 
After the stage-specific regulators are identified, the regulatory interactions between those 
regulators are queried. However, in order to take the factor of time and temporal order, only 
regulatory interactions between regulators of the same stage, or the interactions between 
regulators of a stage and the next time point are queried. As it does not fit into the biological 
logic, for example, for a TF that is active only in the beginning to directly activate another 
gene that is active in the end, or for a TF that is active only in the end to have activated 
another that was present only in the beginning. 
A regulatory mapping between the two sets is the set of edges that are present in the 
regulatory network and have a source gene belonging to the first set and a target gene 
belonging to the second set. Note that this mapping is a directed one where the direction of 
edges goes from the first set to the second. 
 
For 
each time point, a regulatory mapping is performed for the corresponding stage regulators’ 
set against itself. This generates the regulatory interactions between the regulators of the 
stage; we refer to them as intra-regulatory edges.  
 
For each time point, except the last time point, a regulatory mapping is performed for the 
corresponding stage regulators’ set against the regulators’ set of the next stage. This 
generates the regulatory interactions where the regulators of a stage have the potential to 




The cascade is the combination of the peaking regulators' sets, intra-regulatory edges, and 




Definition 3:   , = {  ( , ) ∈    :  ∈      ∈ } 
Definition 4:  =  ,  … ,    where  = (  ,   )  
Definition 6:  ( , ) =  ,  … ,     ℎ re:     = {  ,     } 






To adjust the temporal regulatory cascade, we use three primary parameters: 
 minE: The minimum required expression level of a gene. This represents a threshold 
that filters out genes that are lowly expressed despite their peaking patterns. A gene 
that does not have an expression level higher than this threshold in any of the 
replicates or time points is eliminated and omitted from the calculation that leads to 
the TRC.  
 
 minC: The minimum required correlation between a gene and a TPP to qualify as a 
peaking gene. This cutoff threshold eliminates every gene that is not correlated to the 
TPP related to that stage with a high enough correlation. Genes that make it above 
this threshold and the previous one, provide the initial set of regulators associated 
with each stage. 
 
 maxS: The maximum size of stage-specific regulator’s set, which is the maximum 
number of genes that can be associated with a specific time point. The initial 
regulators associated with a time point based on minC are sorted by their correlation 
to the TPP of that stage, and the top n (maxS) regulators are picked to be in the column 
associated with the stage. If the initial regulators set of a stage has fewer genes, then 
the whole set is taken. The max number of nodes in the cascade is maxS multiplied by 






  Array of genes  G[n] 
 Array of time points T[m] 
 Gene expression matrix D[n][m] 
 RegulatoryNetwork 
  minC 
  minE 
 maxS 
  OnlyRegulators (Boolean)  
 
If ( onlyRegulators ) 
   FilterOutNonRegulatoryGenes (D, G, RegulatoryNetwork) 
 
FilterOutLowExpressedGenes (D, G, minE) 
 
For t in (0 … m): 
        TPP [t] = array [m] (0) 
       TPP [t][t] = 100 
 
For t in (0 … m): 
        intialSet=set() 
       For i in (0 … n): 
             If ( correlation( TPP[t] , D[i] ) > minC ) 
                  intialSet.add(object(G[i], correlation( TPP[t] , D[i] )) 
      RankByCorrelation(intialSet) 
     P[t]= top(intialSet, maxS) 
 
For t in (0 … m): 
        Find all regulatory interactions between the genes in P[t] 
        Find all regulatory interaction between the Genes in P[t] and the Genes in  P[t+1]  
 







5.2.6 Relevant Metrics and Definitions 
The following simple metrics could be used to detect the relevant time points in the dataset 
and to evaluate different cascades: 
 
 PS: The peak strength of a gene is the Pearson correlation of its expression pattern to 
the TPP of the stage t to which it is associated. 
=  ,    
 
 PSS: The peak strength of a stage t is the average of the PSs of the regulators in that 
stage. Stages with a higher PSS contain regulators with a stronger stage-specific 
pattern. 




 PSC: Peak strength of the cascade is the average of peak strengths of the stages in a 
cascade. This metric could be used to evaluate the whole cascade, especially when 
different versions of this cascade are calculated using different parameters. The 







 Intra-Regulatory network: The subset of the cascade composed of a set of stage-
specific genes and the edges between them. In the TRC, it corresponds to the nodes in 
one column and the vertical edges. 
 
For t in (0 … m): 
  Display P[t] in a column of nodes 
 Display Regulatory interactions as connecting edges 






 Inter-Regulatory network: The subset of the cascade composed of a set of stage-
specific genes and the edges outgoing from them to the gene set of the next stage. In 




  Intra-RI: Intra-regulatory influence, the number of outgoing edges from a node in a 
column to other nodes in the same column. 
 
 Inter-RI: Inter-regulatory influence, the number of outgoing edges from a node in a 
column to other nodes in the next column. 
 
 TV: Target value, the number of incoming edges to a node. 
 










































































































































































































5.3 Web Tool 
One of the main goals was to develop a tool that implements the TRC workflow as well as 
other workflows that utilize the power of the background regulatory network to investigate 
aspects of co-expression and co-regulation in a gene expression dataset. The decision on 
implementing the tool in the form of a web service was made as it is easier to reach a wider 
audience of experimentalists who are frequently reluctant to install a software package or 
use complex command lines and pieces of code. The web service offers 4 main workflows, as 
well as five other secondary workflows, each allowing the user to explore the data from a 
different angle (Figure 29). The full web service can be accessed currently at the temporary 
address: 
http://tf-investigator.sybig.de/TRC  
The workflows are interactive and interconnected, allowing the user to use the results of one 
workflow such as a co-expression cluster from the co-expression workflow and ask for 
correlated or enriched regulators that regulate this cluster using the correlated TFs 
workflow. Another example would be of a user using a set of stage-specific regulators of a 
certain time point from the TRC  workflow, asking for the targets genes of these regulators 
using the correlated targets workflow, evaluating this target set using GO enrichment, 
filtering the target set for genes associated with a particular enriched GO term and then using 
this filtered set for a seed-based co-expression analysis.  
This tool offers interactive results networks and sets, which is different from the typical 
black box results of many other methods. These results are usually distilled into a size that 
can facilitate visual inspection and allows the researcher to use biological intuition and his 
background knowledge to focus on particular genes and patterns in the results and 
investigate them deeper, rather than being overwhelmed by an information overload. The 
aim is to allow the researcher to guide the results by eliminating what is not compatible with 
the biological background of the experiment and keeping what makes biologically sense 
through incremental and iterative steps ending with biologically sensible results and new 
insights. 
 
In what follows of this subsection is a detailed description of the main workflows as well as 





Figure 29. An overview of the main components of the web service and its general architecture. 
 
5.3.1 Co-expression Workflow 
This workflow applies a general analysis assuming no prior knowledge of genes of interest 
or patterns. It provides a platform to identify co-expressed genes and to investigate the 
regulatory forces that drive these highly correlated genes to be expressed in a similar 
pattern. It is based on the hypothesis that genes that are highly co-expressed are likely to be 
controlled by a set of common regulators and/or be involved in the same biological process.  
Step 1: The expression data is uploaded and filtered according to different options and 
parameters. The correlation threshold indicates the minimum correlation required for a pair 
of genes to qualify as co-expressed. The expression threshold indicates the minimum 
expression level a gene should have, at least in one of the time points, to qualify for the next 
step of the analysis; this is used to eliminate lowly expressed genes. The user could also 
specifically use only the regulatory genes for the analysis, filter invariant genes, or those with 





Step 2: A co-expression network is constructed using a modified Pearson coefficient based 
on the methodology used in WGCNA [93], with the correlation threshold. 
Step 3: Then, the n largest clusters in the previous network are chosen, and each is reduced 
to the top m hubs. This condenses the co-expression network into its significant components, 
making it easy to analyze visually. By default, in the web workflow, m and n are set to be 10, 
as this produces a relatively concise network that can be visually analyzed. 
Step 4: The user selects a cluster from the displayed reduced network, or a collection of 
genes that might be interesting, then moves to the next workflows to investigate the 
regulators or the targets of this group of genes. 
The co-expression workflow is interactive, where the user can toggle through different 
clusters viewing the general expression pattern of the genes in the side panel and using genes 
in the cluster as seeds for another workflow or a GO enrichment analysis (Figure 30). 
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5.3.2 Seed-Based Co-expression Analysis Workflow 
This workflow is ideal when a small set of genes are previously known to be relevant to the 
experiment. It offers a platform to find genes that are related to the genes of interest in terms 
of pattern, by creating a co-expression network based on the input genes as a seed (Figure 
31). It can be used efficiently to expand on previous knowledge of key genes and find new 
significant candidates. 
Step 1: The expression data is uploaded and filtered according to different options and 
parameters. The correlation threshold indicates the minimum correlation required for a  
gene to be correlated with one of the seed genes to qualify as co-expressed. The expression 
threshold indicates the minimum expression level a gene should have, at least in one of the 
time points, to qualify for the analysis; this is used to eliminate lowly expressed genes. The 
cluster size represents the maximum number of correlated genes to be calculated for each 
seed gene. The user could also specifically use only the regulatory genes for the analysis, 
filter invariant genes, or those with many zero counts, as well as those that have no records 
in the background regulatory network. 
Step 2: Each of the top correlated genes for each seed gene will be included and connected 
to the seed gene to form a cluster around the seed. 
Step 3: The user selects a cluster from the displayed reduced network, or a collection of 
genes that might be interesting, then moves to the next workflows to investigate the 
regulators or the targets of this group of genes. 
The co-expression workflow is interactive, where the user can toggle through different 
clusters viewing the general expression pattern of the genes in the side panel and using genes 






Figure 31. A seed-based co-expression network with the input seeds being ISL1, GATA4, and 
PAX6. The genes connected to each seed represent the top correlated gene; in this case, the 
network is filtered for only TF genes. 
 
5.3.3 Regulatory Analysis Workflow 
This workflow is dedicated to querying TFs and target genes based on the regulatory 
network with or without consideration of the relative expression patterns. The input is a list 
of genes, typically genes known to be involved in a certain pathway or biological process, co-
expressed genes, or any genes of interest. The user can perform a GO enrichment analysis on 
this set or ask for TFs or target genes for this set. The workflow includes an enrichment of 
TFs that target the input list of genes based on a hypergeometric test and the background 
regulatory network, as well as an enrichment of the target genes of the input list in case the 
input list contained some regulators. The user can also ask for TFs or target genes  of the 




TFs or target genes satisfy a certain correlation threshold to the associated gene in the list. 
This correlation threshold can be set by the user as a range from a negative correlation to a 
positive one. And similarly to the other workflows, the minimum expression threshold for 
the genes in the results can be adjusted as a parameter in the interface.  
The result is displayed as a network where the input seed genes are displayed as green nodes 
in the center, and the corresponding TFs or targets are displayed as smaller yellow nodes 
around in a circular formation. The edges are outgoing from the seed gene nodes to the 
corresponding targets in case of analyzing enriched or correlated targets and incoming from 
the TF nodes to the seed nodes in the case of analyzing enriched or correlated TFs. In the 
case of an experimentally verified regulatory interaction, the edge is displayed in red color 
(Figure 32). 
The side panel contains three tabs that display general information about the graph, about 
the edges and nodes, and other features. When clicking on a node, a graph displaying the 
expression pattern across the time points, where the mean of the replicates of a time point 
is used for the plot for simplicity, and a sortable table that summarizes all the nodes 
connected to this node as well as the correlation. Clicking on an edge displays a bar chart 
that shows when the regulatory interaction is active based on the expression levels of the 
regulator, the correlation between the source and the target, and a plot of the expression 
patterns of the source and the target of that edge. The third tab includes features such as 
analyzing the GO enrichment of the set of targets or the set of regulators of the seeds in the 
graph, as well as exporting these sets. 
Options in the top panel allow the user to search for a node in the displayed network, export 
the current view as a high-quality image that can be used for posters, and change the layout 
into the other available ones in the dropdown list. Another option in the top panel is the 
“play” button, which animates the network where genes appear and fade away with across 
time, displaying the plastic nature and the dynamic aspect of the regulatory networks. The 
user can mark nodes and track them as they appear and disappear in different stages, which 
sometimes draws the attention to certain patterns that are not noticed otherwise. The nodes 
and edges don’t change place as in many other dynamic network visualizers, which makes 
the tracking process practical. Another option “highlight stage“ allows the user to compare 
two stages by highlighting one stage and then choosing another. The number and list of 
nodes and edges that appear and disappear between the two stages are displayed in the 










































































































































































































5.3.4 The TRC Workflow 
The opening page of the TRC workflow allows the adjustment of the 3 parameters, minE, 
minC, and maxS (see 5.2.4). The opening page also allows the choice of using only regulators, 
which is the default and part of the essence of the TRC method or removing that restriction 
to generate a cascade that contains non-regulators as well. 
 
After the parameters are chosen, the TRC algorithm runs using the data file uploaded in the 
current session with the parameters and produces the resulting file on the server side. Next, 
the user is forwarded to the TRC interactive visualizer (Figure 33). 
The cascade is animated at a slow pace, where the genes associated with the first stage are 
displayed as nodes in a column formation with the intra-regulatory interactions represented 
as vertical edges between them. The inter-regulatory interactions are animated next as 
edges coming out from the just animated genes, and the targets which are the genes from the 
next stage pop up next, and it goes on.  
As the intra-regulatory edges are hard to see, being mostly hidden behind the nodes to give 
maximum visibility to the names of the genes in the nodes, the user can click on the stage 
header, which opens a window dedicated to the intra-regulatory network of this stage.  
In the side panel, three tabs are accessible to provide information about the graph in general, 
the stage and the genes within, information around the node or edge clicked, and links for 
further analyzing gene sets in the other workflows or external ones.  
The details panel, when clicking on a stage, offers a plot of the expression patterns of all the 
genes in that time point, the average peak strength of the stage and a sortable table that 
summarizes different useful metrics for the nodes belonging to that stage such as indegree 
and intra-regulatory influence. When a node is clicked, the details panel displays the 
expression pattern of the gene, the peak strength of the gene as well as a table that 
summarizes all the nodes connected to this node. When an edge is clicked, a plot that 
compares that expression patterns of the two connected genes of the edge is displayed, along 
with the correlation. 
The last panel contains an editable text area that displays the list of genes contained in a 
certain time point that is clicked. The user can fill in, delete, or add any genes besides the 
default stage-specific ones that are automatically filled. This set can be used as a seed for any 
of the other secondary workflows, where the parameters to that workflow can be adjusted 





















































































































































The analysis of time series datasets and the generation of the TRC in a file format was 
implemented in java, and available as a jar file that takes an expression file, a regulatory 
network and the main TRC parameters and outputs a file containing the TRC in a format 
that is directly usable by the web visualizer.  
 
The generation of the network utilized C as a fast programming language for the initial steps 
and SQL for storing the binding site predictions and relevant information. After that, java 
was used for organizing the network and transforming it into a graph database as well as 
file formats  that can be used in the different workflows. 
 
The web tool utilized PHP for the server end, and a combination of javascript, jQuery, and 
HTML for the client end. The visualization process of the plastic network and the TRCs relied 
heavily on javascript. The library cytoscape.js was used for visualizing nodes and edges and 
styling them.  
For the visualization of the TRC model, we needed to create a custom layout to organize the 
nodes and edges in the required architecture and display it in an animated manner. I created 
a simple layout algorithm to organize the nodes in a specific architecture then display the 
nodes and edges as the time points unfold. The algorithm determining the position of each 
node goes as follows: 
For each node in the layout, the following attributes are created: 
 Column: index of the stage *2 . This means each stage gets an even column for its nodes, 
and the odd columns remain empty. This firstly creates a clearer layout in the cascade with 
enough space between the full columns. Secondly, it creates distance, so the edges between 
the time points can be drawn effectively. 
 Row: The number of rows to be drawn is determined by the column with the highest 
number of nodes. After which the nodes are filled bottom up according to their sorted 
indices. 
 Color: the color of the node is determined by the index of the stage it belongs to. These 
colors are preprogrammed, where each index from 0 till the max columns allowed contains 
a color that follows the natural color spectrum and yet is contrasting enough with the 
column before and after. 
Once each node is given a position defined by a particular row and column in the grid, these 




zoom in levels. An adapter included within the cytoscape.js library is used to transform grid 
indices into physical locations. 
Animation: 
1. All nodes and edges are hidden. 
2.  For each time point or column:  
- Display the nodes associated with the column: nodes are unhidden, and their size is 
progressively grown from zero to the full size. 
- Display the edges associated with this column: reveal all the edges that are within 
that time point and the edges outgoing from the nodes in that column.  
- Wait for a few seconds to allow the nodes to fully animate, then lunch the next 
iteration. 
 
For the regulatory network, we wanted a layout that displays nodes and as they fade in and 
out across the time without changing their locations as most of the tools do when displaying 
a dynamic network. This allows the user to keep track of the important nodes and be able 
to compare them as they change their expression through the stages. 
Placement of the nodes: The seed genes, whether they are genes querying their regulators 
or genes querying their target genes, are placed inside a circle, and the queried regulators 
or targets are displayed in the parameter of this circle. This is achieved through a concentric 
layout based on the in or out-degree. Edges go outwards in the case of querying the targets 
and inwards into the seeds in the case of querying the regulators of the seeds. 
Animation: The network can be animated, activating the  genes that are expressed in the 
first condition, while the other nodes, though visible, are faded to indicate their lack of 
expression at that time point. Edges that originate from a faded node disappear while those 
that originate from an active node are activated. After a small time delay to allow the user 
to skim through the time point snapshot of the network, the animation proceeds to activate 
the nodes of the next time point and fading those that are not expressed next. During the 
animation, information about the transitions can be obtained, such as the number and lists 
of nodes that disappeared during the transition, the number of appearing and disappearing 








5.4 Heat Development Dataset Analysis 
This subsection covers the analysis of the heart development dataset from different angles, 
aspects, and approaches.  
5.4.1 TRC Analysis 
The TRC was generated for the heart development dataset, and stage-specific key regulators 
and their interactions were detected. As a general overview, each time point in the TRC has 
at least 8 regulators associated with it, and most of the stages had 10, summing up to 76 
regulators overall (Figure 34). The TRC contained no microRNAs, so all the regulators in it 
were TFs. All the stages were connected and contained intra-regulatory interactions. We 
performed a detailed analysis of each stage, focusing on the following: 
 
1) The GO enrichment of the stage-specific regulators and the relevance of the terms to the 
differentiation events observed experimentally at that time point. 
2) The identity of each of the regulators in that stage and a literature search on their general 
and specific roles and any experimental evidence of their involvement in cardiac 
development. 
3) The regulatory interactions between the stages. 
4) The intra-regulatory network of the stage and potential master regulators.  
5) Potential co-regulators that might control the expression of the stage-specific regulators 
set. 
6) Targets of the stage-specific regulators and their GO enrichment. 
7) Potentially collaborating TF pairs that control the regulators set, and potential proximal 
binding sites used for these collaborations in the promoters of common targets. 
8) Potential new regulatory candidates that might be important for cardiac differentiation 








































































Regulators of Day -1 (Figure 35) showed enrichment of general GO terms like regulation of 
transcription, which is biased in our case due to the restriction of the list to regulators; 
however, no specific terms appeared (Table 3). This is expected since, at this time point, the 
differentiation has not started yet, and the time point is a mere control, so we didn’t expect 
to see any terms related to cardiac development or specific processes. Analyzing this stage 
was important for the cascade serving as a control, where the detected regulators in the 
other stages have to satisfy the condition of being lowly or non- expressed at this stage as a 
natural consequence of the TRC method. 
Table 3. The top GO terms enriched for the regulators specific to Day -1. 
GO Term # Ref. 








  P - 
value 
positive regulation of transcription by RNA 
polymerase II  1214 
  9 .58 15.57  +   6.32E-07 
positive regulation of transcription, DNA-templated  1547   9 .74 12.21  +   5.47E-06 
positive regulation of nucleic acid-templated 
transcription  1634 
  9 .78 11.56  +   8.90E-06 
positive regulation of RNA biosynthetic process  1635   9 .78 11.56  +   8.95E-06 
positive regulation of RNA metabolic process  1719   9 .82 10.99  +   1.40E-05 
positive regulation of nucleobase-containing 
compound metabolic process  1881 
  9 .90 10.05  +   3.11E-05 
positive regulation of macromolecule biosynthetic 
process  1899 
  9 .90 9.95  +   3.39E-05 
positive regulation of cellular biosynthetic process  1985   9 .95 9.52  +   5.02E-05 
positive regulation of gene expression  1998   9 .95 9.46  +   5.32E-05 
positive regulation of biosynthetic process  2018   9 .96 9.36  +   5.81E-05 
negative regulation of gene expression  1716   7 .82 8.56  +   2.11E-02 
regulation of transcription by RNA polymerase II  2699   10 1.29 7.78  +   1.12E-05 
positive regulation of nitrogen compound metabolic 
process  3173 
  10 1.51 6.62  +   5.62E-05 
positive regulation of cellular metabolic process  3314   10 1.58 6.34  +   8.67E-05 
positive regulation of macromolecule metabolic 
process  3343 








Figure 35. The intra-regulatory network corresponding to Day -1 the control stage. 
Day 0 
 
Similarly, Regulators of Day 0 (Figure 36) showed enrichment of general GO terms like 
regulation of transcription, which is biased in our case due to the restriction of the list to 
regulators, and no specific terms appeared (Table 4). This is also expected since at this time 
point the seeding of the stem cells has just finished, the mesoderm induction is about to start, 
and the differentiation has not started yet, so we didn’t expect to see any terms related to 
cardiac development or specific processes yet. Analyzing this stage was not of importance, 
but it was also serving as a control in the TRC, where the detected regulators in the other 
stages have to satisfy the condition of being lowly or non-expressed at this stage as a natural 






Table 4. The top GO terms enriched for the regulators specific to Day 0. 











positive regulation of transcription by RNA 
polymerase II  1214 9 .58 15.57 + 6.32E-07 
positive regulation of transcription, DNA-templated 1547 9 .74 12.21 + 5.47E-06 
positive regulation of nucleic acid-templated 
transcription  1634 9 .78 11.56 + 8.90E-06 
positive regulation of RNA biosynthetic process  1635 9 .78 11.56 + 8.95E-06 
positive regulation of RNA metabolic process  1719 9 .82 10.99 + 1.40E-05 
positive regulation of nucleobase-containing 
compound metabolic process  1881 9 .90 10.05 + 3.11E-05 
positive regulation of macromolecule biosynthetic 
process  1899 9 .90 9.95 + 3.39E-05 
positive regulation of cellular biosynthetic process  1985 9 .95 9.52 + 5.02E-05 
positive regulation of gene expression  1998 9 .95 9.46 + 5.32E-05 
positive regulation of biosynthetic process  2018 9 .96 9.36 + 5.81E-05 
regulation of transcription by RNA polymerase II  2699 10 1.29 7.78 + 1.12E-05 
regulation of transcription, DNA-templated  3516 10 1.67 5.97 + 1.57E-04 
positive regulation of nitrogen compound metabolic 
process  3173 9 1.51 5.96 + 3.20E-03 
regulation of nucleic acid-templated transcription  3574 10 1.70 5.87 + 1.84E-04 








Figure 36.   The intra-regulatory network corresponding to Day 0. POU2F3 being heavily 





Day 3 marks the end of the mesoderm induction face, where CHIR99021, FGF-2, BMP4, 
Activin-A have been added for three days. The GO enrichment showed very specific and 
biologically consistent terms (Table 5). The top terms sorted by fold enrichment and 
satisfying a p-value >0.05 were overwhelmingly related to mesoderm formation, stem cell 
specification, cardiac cell fate determination, embryonic development, primary germ layer 
formation, and heart morphogenesis. This enrichment is very consistent with the fact that 
the stem cells have differentiated into mesodermal cells by Day 3. These mesodermal cells 
provide the basis for the cardiac differentiation that follows. This enrichment gives a certain 
level of confidence that these 10 regulators specific for Day 3, detected by the TRC, are indeed 





Table 5. The top GO terms enriched for the regulators specific to Day 3. 











stem cell fate specification  4 2 .00 > 100 + 3.33E-02 
negative regulation of mesodermal cell 
differentiation  4 2 .00 > 100 + 3.33E-02 
negative regulation of mesodermal cell fate 
specification  4 2 .00 > 100 + 3.33E-02 
cardiac cell fate determination  4 2 .00 > 100 + 3.33E-02 
negative regulation of Wnt signaling pathway 
involved in heart development  5 2 .00 > 100 + 4.66E-02 
signal transduction involved in regulation of gene 
expression  20 3 .01 > 100 + 1.68E-03 
negative regulation of embryonic development  26 3 .01 > 100 + 3.45E-03 
regulation of gastrulation  37 3 .02 > 100 + 9.30E-03 
somitogenesis  66 3 .03 86.76 + 4.89E-02 
formation of primary germ layer  113 5 .06 84.46 + 2.06E-05 
regulation of embryonic development  129 5 .07 73.98 + 3.91E-05 
gastrulation  159 6 .08 72.03 + 8.54E-07 
mesoderm development  126 4 .07 60.59 + 3.98E-03 
regionalization  334 9 .17 51.43 + 3.54E-11 
anterior/posterior pattern specification  218 5 .11 43.78 + 5.04E-04 
pattern specification process  433 9 .23 39.67 + 3.52E-10 
heart morphogenesis  250 5 .13 38.17 + 9.83E-04 
 
 
The regulators of Day 3 were MESP1, GSC, CDX1, EVX1, MESP2, SP5, SOX17, LHX1, SNAI1, 
PITX2 (Figure 37). We examined the function of each regulator. MESP1 ( Mesoderm Posterior 
BHLH Transcription Factor 1 ) and MESP2 ( Mesoderm Posterior BHLH Transcription Factor 
2 ) are TFs known to be essential for the formation of the cardiac mesoderm [94]. MESP1 is 
one of the earliest TFs that gives rise to a set of cardiac-specific TFs [95]–[99]. This fact fits 




regulating 3 TFs CDX1, EVX1, SNAI1 and at the same time, not being regulated by any. 
Although MESP1 and MESP2 share a lot in common in terms of their structure and 
transcriptional targets, their roles are not completely redundant [100]–[104]. Experiments 
have shown that the knockout of one of them is not covered for by the other, and the effects 
are fatal for the heart. ChIP-seq experiments have shown that MESP1 has unique and specific 
targets such as RASGRP3 and PRICKLE, and controls the speed and direction of cell migration 
[105]. GSC is another TF observed peaking in Day 3 and known to be one of the markers of 
mesendoderm [106], and known as well to be regulated by MESP1, however the ChIP-seq 
analysis showed that MESP1 binds around 5 Kb upstream of GSC and have been 
hypothesized to act more of an enhancer of GSC [107]. However, In the intra-network of Day3 
we can show that MESP1 is also able to regulate the expression of GSC indirectly via 
CDX1which might also explain its influence on its expression in an indirect way. CDX1 is the 
most active node in the intra-network of Day 3, regulated by four Day 3 regulators as well as 
regulating 2 others and itself. This predicted auto-regulation of CDX1 is also experimentally 
verified [108]. CDX1 is also known to be involved in the differentiation and proliferation of 
different cell types, including cardiac cells [109]–[112], which indicates that its role is more 
general in proliferation rather than being responsible for the cardiac specification. SP5 is a 
known marker for mesoderm [113] and a target of the Wnt/β-catenin signaling pathway 
[114], however the regulatory analysis in the Day 3 network shows that its role might be 
indirectly regulating the critical TFs CDX1 and SOX17. SOX17 has been shown to be essential 
for the specification of cardiac mesoderm in mice [115], and here we can hypothesize that 
this also applies to human cardiac cells. SOX17 might function as one of the direct regulators 
of CDX1 and potentially collaborating with some other Day 3 regulators such as MESP1, 
MESP2, and SP5 in regulating it, or contributes to potential redundancy in the regulation of 
this essential TFs providing more robustness to the network by protecting the central node. 
SNAI1 is a zinc finger transcription factor that has been shown to promote the exit from the 
pluripotency by direct repression of self-renewal genes [116] [117]. The regulatory network 
shows that MESP1 and MESP2 might be responsible for the induction of SNAI1 and the 
resulting repression cascade. Some studies have shown that PITX2, another TF peaking in 
Day 3, regulates the left-right asymmetry by patterning second cardiac lineage-derived 
myocardium. EVX1 is another Day 3 TF that is required for patterning and gastrulation 
[118]–[120].  LHX1 does not appear in the intra-network due to the lack of its involvement 
in any intra-regulatory interactions; however, it is known for its involvement in the 
formation of the epithelium [121], in this case, we can see its potential involvement in the 






Figure 37.  The intra-regulatory network corresponding to Day 3. 
 
Figure 38.  (Left) The top correlated regulators of SNAI1. (Right) The anti-correlated patterns 
of ELK4 and SNAI1. 
 
Interestingly many TFs in this set are involved in cancer and tumor genesis, such as SNAI1, 
which marks highly resistant tumors [122]. It is not clear whether the expression of SNAI1 
is assisting the tumor growth or is a response to fight the tumor growth.  We investigated 




appeared to be regulating it, besides MESP1 and MESP2 (Figure 38). However, what is 
interesting about ELK4 is its strong anti-correlating pattern, which might indicate its 
repressive influence on SNAI1 and might be a potential drug target for combating tumors by 
reducing the expression of SNAI1. 
Studying the targets of the Day 3 TFs, we queried the regulatory network for targets of these 
TFs that have a correlation between -0.7 and 0.7 to its regulator and resulted in 94 target 
genes. The GO enrichment of the target gene set was related to gastrulation, regionalization, 
pattern specification, chromatin assembly and disassembly, and the formation of a primary 
germ layer (Table 6). These terms are perfectly consistent with the biology underlying the 
events at Day 3, where the chromatin is being opened for a wave of cardiac-specific 
regulatory events, and the mesodermal layer is formed providing the basis for the upcoming 
more specific layer of cardiac cells and shows that the targets of these TFs are also specific 
and constitute part of the wave.  
Table 6. The GO enrichment of the targets of Day 3 TFs. 











signal transduction involved in regulation of 
gene expression  20 4 .09 44.67 + 3.29E-02 
formation of primary germ layer  112 7 .50 13.96 + 9.30E-03 
nucleosome assembly  116 7 .52 13.48 + 1.16E-02 
gastrulation  158 9 .71 12.72 + 5.27E-04 
chromatin assembly  133 7 .60 11.76 + 2.77E-02 
chromatin assembly or disassembly  154 8 .69 11.60 + 5.80E-03 
regionalization  337 13 1.51 8.62 + 4.66E-05 
pattern specification process  433 14 1.94 7.22 + 1.00E-04 
Unclassified  3156 3 14.13 .21 - 0.00E00 
  
Furthermore, we investigated whether the TFs of Day 3 collaborate in the regulation of the 
target set and for that, we utilized the PC-TraFF algorithm. We ran the extended version of 
the PC-raff algorithm, searching for potential TF  collaborations that utilize the PWMs 
associated with the TFs of Day 3 in the promoter regions of the correlated target set of these 
regulators. The maximal distance between the pairs was chosen as 20, and the z-score cutoff 
was 3.  One collaborating pair was detected to be specific for this set, and that was 




CDX1, which suggests the potential utilization of CDX1 of proximal binding sites in the 




Regulators of Day 8 show very specific cardiac terms in the GO enrichment, such as 
ventricular cardiac muscle differentiation, cardiocyte differentiation, and heart 
morphogenesis (Table 7). These terms go very well in accordance with the biological events 
happening in the experiment at this stage. At Day 8, early cardiac specification is occurring, 
and cells are starting to differentiate into not-yet mature cardiomyocytes.  
Table 7. The GO enrichment of the TFs of Day 8. 











ventricular cardiac muscle cell differentiation  18 3 .01 > 100 + 9.20E-04 
pharyngeal system development  26 3 .01 > 100 + 2.52E-03 
cell fate determination  42 3 .02 > 100 + 9.76E-03 
cardiac ventricle morphogenesis  72 3 .03 87.48 + 4.61E-02 
cardiocyte differentiation  116 4 .06 72.40 + 1.85E-03 
cardiac muscle tissue development  159 5 .08 66.03 + 5.96E-05 
cellular response to steroid hormone stimulus  187 4 .09 44.91 + 1.19E-02 
mesenchyme development  216 4 .10 38.88 + 2.09E-02 
striated muscle tissue development  285 5 .14 36.84 + 1.03E-03 
muscle tissue development  298 5 .14 35.23 + 1.28E-03 
heart morphogenesis  249 4 .12 33.73 + 3.65E-02 
regulation of animal organ morphogenesis  256 4 .12 32.81 + 4.06E-02 
gland development  417 5 .20 25.18 + 6.63E-03 
heart development  528 6 .25 23.86 + 4.52E-04 




tissue morphogenesis  560 6 .27 22.50 + 6.39E-04 
 
The main regulator that stands out at this stage is MEF2C, a heavily regulated TF by both 
regulators of the previous stage and the same stage, with 13 incoming edges (Figure 39). 
MEF2C is essentially known to be one of, if not the most essential TF for cardiomyocyte 
development and specification, cooperating and interacting with other cardiac factors and 
forming the core of the cardiac differentiation regulatory network [123]–[129]. The 
observed heavy regulation of MEF2C can be either due to a precise simultaneous corporation 
between the TFs binding to its promoter which leads to its activation exactly at that time 
point, or redundancy in the function of these TFs in activating MEF2C  providing the 
robustness needed in case one of the activators was eliminated. SP6 regulates 3 TFs, SOX10, 
MEF2C, and GATA2 in the network and is not regulated by any other TF, making it a potential 
master regulator of the Day 8 regulatory network. Although there is no particular evidence 
in the literature of the involvement of SP6 in cardiac development and differentiation, we 
hypothesize that its role might be crucial in the specification stage, and provides a good 
candidate for further experimental investigation.  PRRX2 is another regulator in this 
network, regulating MEF2C and GATA2, and is involved in vascular smooth muscle 
differentiation [130]. Observing it coexpressed and peaking at this stage of cardiac 
specification hints to either its additional role in cardiac muscle cell development or, more 
probably, its role as a key regulator that initiates the development of a vascular network that 
supplies blood and is integrated within the developing heart. This indicates that knocking 
out PRRX2 might enhance the purity of the cardiomyocyte culture in the experiment by 
eliminating the development of vascular smooth muscle cells within. GATA2 appears to be 
peaking in Day 8 as well , however little is known about its role in cardiac differentiation. As 
it belongs to the same family like GATA4 and GATA5 which are important in cardiac 
differentiation, we hypothesize that its role here is redundant. GATA5, a TF required of 
cardiac differentiation [131]–[134], appears specifically on Day 8. SOX10 is another active 
regulator in Day 8,  has little evidence for its  involvement in cardiac differentiation however 
provides a good candidate for experimental investigation due to involvement of other SOX 
family members such as SOX4 and SOX11 that are heavily involved in cardiac differentiation 
[135]–[137] thus it could be taking over some of their roles. NKX2-6 is an understudied TF 
in the literature; however, it is very specific Day 8 expression coupled with the fact that 
NKX2-5 another family member of the NK-2 homeobox family is one of the most essential 
TFs for cardiac development [131][132]opens the question about its potential involvement 
in cardiac differentiation. Worth to notice that NKX2-5 and NKX2-6 are both homologs of the 
of drosophila homeobox-containing protein called 'tinman', which has been shown to be 
essential for the development of the heart-like dorsal vessel [140]. ISL1, which regulates 
itself as well as regulating MEF2C on Day 8 , is known to be another crucial TF for cardiac 
specification [95], [141]–[146]. Strong experimental evidence exists for MEF2C being a 
direct transcriptional target of ISL1 and GATA factors in the embryonic heart [147], which 





Figure 39.  The intra-regulatory network corresponding to Day 8. MEF2C being heavily 
regulated by the TFs of the previous stage with 5 incoming inter-regulatory edges. 
Studying the targets of the Day 8 TFs, we queried the regulatory network for targets of these 
TFs that have a correlation between -0.7 and 0.7 to its regulator and resulted in 154 target 
genes, a much wider set of correlated targets than in Day 3. The GO enrichment of the target 
gene set was just like the TFs very cardiac-specific. Terms ranged from ventricle formation, 
valve morphogenesis, to cardiac differentiation. These terms are perfectly supported by the 
events going on in Day 8, where the cardiac specification is happening, and immature 
cardiomyocytes are appearing. The complete list of the Day 8 specific target set can be found 






Table 8 .  The GO enrichment of the  targets of Day 8 TFs. 











cardiac right ventricle morphogenesis  19 7 .14 50.23 + 4.96E-06 
cardiac chamber formation  11 4 .08 49.58 + 3.10E-02 
pulmonary valve morphogenesis  17 5 .12 40.10 + 4.09E-03 
aortic valve morphogenesis  28 7 .21 34.08 + 4.80E-05 
pulmonary valve development  21 5 .15 32.46 + 9.97E-03 
atrioventricular valve development  26 6 .19 31.46 + 9.37E-04 
aortic valve development  32 7 .23 29.82 + 1.07E-04 
semi-lunar valve development  37 8 .27 29.48 + 1.01E-05 
atrioventricular valve morphogenesis  24 5 .18 28.40 + 1.77E-02 
heart valve morphogenesis  52 9 .38 23.60 + 5.11E-06 
cardiac ventricle morphogenesis  72 12 .53 22.72 + 9.27E-09 
cardiac atrium morphogenesis  30 5 .22 22.72 + 4.67E-02 
heart valve development  61 10 .45 22.35 + 8.81E-07 
endocardial cushion development  45 6 .33 18.18 + 1.66E-02 
ventricular cardiac muscle tissue 
development  55 7 .40 17.35 + 2.98E-03 
ventricular cardiac muscle tissue 
morphogenesis  48 6 .35 17.04 + 2.34E-02 
cardiac ventricle development  128 15 .94 15.98 + 1.32E-09 
myofibril assembly  61 7 .45 15.65 + 5.66E-03 




cardiac muscle tissue morphogenesis  64 7 .47 14.91 + 7.62E-03 
ventricular septum development  72 7 .53 13.26 + 1.58E-02 
muscle tissue morphogenesis  75 7 .55 12.72 + 2.04E-02 
muscle cell development  146 13 1.07 12.14 + 1.40E-06 
cardiac chamber development  170 15 1.25 12.03 + 5.78E-08 
cardiocyte differentiation  116 10 .85 11.75 + 2.61E-04 
 
Furthermore, we investigated whether the TFs of Day 3 collaborate in the regulation of the 
target set, and for that, we utilized the PC-TraFF algorithm. We ran the extended version of 
the PC-raff algorithm, searching for potential TF  collaborations that utilize the PWMs 
associated with the TFs of Day 8 in the promoter regions of the correlated target set of these 
regulators. The maximal distance between the pairs was chosen as 20, and the z-score cutoff 
was 3.  The result was 10 potentially collaborating PWM pairs (Table 9), among which 9 were 
specific to this set. While most pairs were composed of PWMs associated with the same TF, 
with SP5 associated with 6 of these pairs, 3 pairs stood out where the PWMs belonged to 
different TFs: V$ISL2_05 - V$PRX2_Q2, V$ISL2_02 - V$PMX1_Q6, and V$GATA6_04 - 
V$PMX1_Q6.  
V$ISL2_05 - V$PRX2_Q2 and V$ISL2_02 - V$PMX1_Q6 point to the potential collaboration of 
PRRX2 and ISL1 in regulating a set of targets. Furthermore, V$GATA6_04 - V$PMX1_Q6 
points to the potential collaboration of GATA2 and/or GATA5 with PRRX2 to regulate a set 
of targets. 
 
Table 9. The potentially collaborating PWM pairs found in the promoters of the target set of 
the Day 8 TFs. 
Matrix 1 Matrix 2 Z-score Background Difference 
V$PRX2_Q2 V$PMX1_Q6 4.750444077 -0.001241656 
V$SP1_Q6_01 V$SP1_Q2_01 3.594553147 0.002856102 
V$SP1_Q6 V$SP1_Q4_01 3.113176652 0.002223333 
V$GATA6_04 V$PMX1_Q6 3.001578304 0.001683787 
V$SP1_Q2_01 V$SP1_03 3.941624451 0.004473108 
V$ISL2_05 V$PRX2_Q2 3.692424705 0.003380307 
V$ISL2_02 V$PMX1_Q6 3.300999227 0.001934722 
V$SP1_Q2_01 V$SP1_02 5.099317264 0.005619215 
V$SP1_02 V$SP1_03 6.730314615 0.005515271 







In contrast to the previous stage, regulators of Day 13 (Figure 40) showed enrichment of 
general GO terms like regulation of transcription, which is biased in our case due to the 
restriction of the list to regulators, and no specific terms appeared (Table 10). This indicates 
that no novel or unique activity happens on Day 13 that stands out from another stage. 
However, the expression profile of some important cardiac TFs such as NKX2-5 and GATA4 
showed that these factors are present in Day13, but their expression starts on Day 8, after 
which they continue being expressed till Day 29, but that doesn’t make them unique for Day 
13.  The target set of the TFs at this stage showed no significant enrichment at all. 
 
Table 10. The GO terms enriched in the TFs of Day 13. 











positive regulation of transcription by RNA 
polymerase II  1212 8 .46 17.32 + 1.13E-06 
positive regulation of transcription, DNA-
templated  1553 8 .59 13.52 + 8.19E-06 
positive regulation of nucleic acid-templated 
transcription  1651 8 .63 12.72 + 1.33E-05 
positive regulation of RNA biosynthetic process  1652 8 .63 12.71 + 1.34E-05 
positive regulation of RNA metabolic process  1736 8 .66 12.09 + 1.99E-05 
positive regulation of nucleobase-containing 
compound metabolic process  1897 8 .72 11.07 + 4.04E-05 
positive regulation of macromolecule 
biosynthetic process  1919 8 .73 10.94 + 4.43E-05 
positive regulation of cellular biosynthetic 
process  2007 8 .76 10.46 + 6.34E-05 
positive regulation of gene expression  2011 8 .77 10.44 + 6.44E-05 
positive regulation of biosynthetic process  2039 8 .78 10.30 + 7.19E-05 




positive regulation of nitrogen compound 
metabolic process  3203 8 1.22 6.56 + 2.65E-03 
positive regulation of cellular metabolic process  3344 8 1.27 6.28 + 3.74E-03 
positive regulation of macromolecule metabolic 
process  3375 8 1.29 6.22 + 4.02E-03 















Just like the previous stage, regulators of Day 22 showed enrichment of general GO terms 
like regulation of transcription, which is biased in our case due to the restriction of the list 
to regulators, and no specific terms appeared (Table 11). This indicates that no novel or 
unique activity happens on Day 22 that stands out from another stage. However, as 
mentioned before,  the expression profile of a cluster of cardiac TFs showed that these factors 
in it are present on Day 22, but their expression spans from Day 8 till Day 29, but that but 
not particularly unique for Day 22.  The target set of the TFs at this stage showed no 
significant enrichment at all. 
 
Table 11. The GO terms enriched in the TFs of Day 22. 












regulation of transcription by RNA polymerase 
II  2294 8 1.09 7.32 + 6.75E-03 
regulation of transcription, DNA-templated  3467 9 1.65 5.45 + 7.03E-03 
regulation of nucleic acid-templated 
transcription  3534 9 1.68 5.35 + 8.32E-03 
regulation of RNA biosynthetic process  3539 9 1.69 5.34 + 8.42E-03 
regulation of RNA metabolic process  3785 9 1.80 4.99 + 1.52E-02 
regulation of cellular macromolecule 
biosynthetic process  3908 9 1.86 4.84 + 2.02E-02 
regulation of nucleobase-containing compound 
metabolic process  4040 9 1.92 4.68 + 2.70E-02 
regulation of macromolecule biosynthetic 
process  4046 9 1.93 4.67 + 2.73E-02 
regulation of cellular biosynthetic process  4185 9 1.99 4.52 + 3.68E-02 












Just like the previous stage, regulators of Day 29 (Figure 42) showed enrichment of  general 
GO terms like regulation of transcription, which is biased in our case due to the restriction 
of the list to regulators, and no specific terms appeared. This indicates that no novel or 
unique activity happens on Day 29 that stands out from another stage. However, as 
mentioned before,  the expression profile of a cluster of cardiac TFs showed that these factors 
are present on Day 29, but their expression spans from Day 8 till Day 29, but that but not 







Table 12. The GO terms enriched in the Day 29 TFs. 











negative regulation of transcription by RNA 
polymerase II  880 6 .38 15.91 + 3.73E-03 
negative regulation of transcription, DNA-
templated  1208 7 .52 13.52 + 6.19E-04 
negative regulation of nucleic acid-templated 
transcription  1261 7 .54 12.95 + 8.32E-04 
negative regulation of RNA biosynthetic process  1263 7 .54 12.93 + 8.41E-04 
negative regulation of RNA metabolic process  1354 7 .58 12.06 + 1.36E-03 
negative regulation of cellular macromolecule 
biosynthetic process  1399 7 .60 11.67 + 1.70E-03 
negative regulation of nucleobase-containing 
compound metabolic process  1456 7 .62 11.22 + 2.23E-03 
negative regulation of macromolecule 
biosynthetic process  1481 7 .63 11.03 + 2.51E-03 
negative regulation of cellular biosynthetic 
process  1539 7 .66 10.61 + 3.26E-03 
negative regulation of biosynthetic process  1566 7 .67 10.43 + 3.67E-03 
negative regulation of gene expression  1738 7 .74 9.40 + 7.49E-03 
regulation of transcription by RNA polymerase II  2294 8 .98 8.14 + 1.50E-03 
regulation of transcription, DNA-templated  3467 8 1.49 5.38 + 3.83E-02 
regulation of nucleic acid-templated transcription 3534 8 1.51 5.28 + 4.45E-02 








Figure 42.   The intra-regulatory network corresponding to Day 29. 
 
Studying the targets of the Day 29 TFs, we queried the regulatory network for targets of these 
TFs that have a correlation between -0.7 and 0.7 to its regulator and resulted in 466 target 
genes, a much wider set of correlated targets than in other time points. Despite the fact that 
the TF set had no specific enrichment terms, their target gene set was enriched for cardiac 
conduction and heart muscle contraction, a sign of mature cardiomyocytes. This particular 
set is of interest for the corresponding experiment, as one of the goals was to enhance the 
contraction strength of the resulting Cardiomyocytes; Thus, overexpressing these TFs might, 
in  turn, raise the expression of the genes in this target set and result in a stronger 
contraction. However, further investigation needs to be done to distill the target set into 
those genes involved only in muscle contraction and identifying their regulators. The 








Table 13. The GO enrichment of the targets of D29 TFs. 











regulation of striated muscle contraction  94 13 2.09 6.23 + 5.12E-03 
muscle organ morphogenesis  82 11 1.82 6.04 + 4.94E-02 
muscle cell development  146 17 3.24 5.25 + 9.27E-04 
striated muscle cell development  133 15 2.95 5.08 + 7.54E-03 
regulation of muscle contraction  163 18 3.62 4.98 + 8.14E-04 
regulation of muscle system process  236 24 5.24 4.58 + 2.61E-05 
cardiac muscle tissue development  159 16 3.53 4.53 + 1.31E-02 
regulation of heart contraction  243 23 5.39 4.26 + 1.92E-04 
muscle tissue development  298 27 6.61 4.08 + 2.70E-05 
muscle system process  294 26 6.53 3.98 + 8.42E-05 
striated muscle tissue development  285 25 6.33 3.95 + 1.89E-04 
regulation of blood circulation  290 25 6.44 3.88 + 2.59E-04 
muscle cell differentiation  245 21 5.44 3.86 + 3.65E-03 
muscle contraction  246 21 5.46 3.85 + 3.88E-03 
muscle organ development  295 25 6.55 3.82 + 3.53E-04 
muscle structure development  480 39 10.65 3.66 + 1.63E-07 
Day 60 
 
This stage has special properties, as its enrichment contains no cardiac relevant terms but 
neural development terms instead. Enriched terms contained terms such as amacrine cell 
(inhibitory neuron) differentiation, neurogenesis, and neural system development. This 
might seem like an error, a methodological problem, or a coincidence; however, the 
experimental observation showed otherwise. Experimentalists monitoring this particular 
experiment have observed that after the cardiac cells mature in Day 60, a group of neural 
cells start emerging in the culture and almost dominate the culture by Day 60. Thus this 








Table 14. The GO terms enriched in the D60 TFs. 












amacrine cell differentiation  5 2 .00 > 100 + 3.83E-02 
positive regulation of transcription regulatory 
region DNA binding  25 3 .01 > 100 + 2.26E-03 
regulation of transcription regulatory region DNA 
binding  53 3 .03 > 100 + 1.90E-02 
positive regulation of DNA binding  56 3 .03 > 100 + 2.23E-02 
neural retina development  65 3 .03 96.90 + 3.43E-02 
retina development in camera-type eye  148 5 .07 70.93 + 4.20E-05 
camera-type eye development  317 6 .15 39.74 + 2.25E-05 
eye development  357 6 .17 35.29 + 4.53E-05 
visual system development  361 6 .17 34.90 + 4.84E-05 
sensory system development  366 6 .17 34.42 + 5.24E-05 
sensory organ development  553 6 .26 22.78 + 5.93E-04 
regulation of transcription by RNA polymerase II  2294 10 1.09 9.15 + 2.22E-06 
neurogenesis  1649 7 .79 8.91 + 1.62E-02 
nervous system development  2357 9 1.12 8.02 + 2.32E-04 
 
A central node in the intra-regulatory network of Day 60  is PAX6, with three regulators and 
three targets in the network (Figure 43). PAX6 (Paired Box 6) is a TF that is crucial in the 
neural cell fate determination and sensory development [148]–[158]. This crucial 
experimentally verified role of PAX6 goes very well with its central location in the intra-
network and well-peaked pattern specific for Day 60 . BHLHE22 is another active hub in the 




it is  coexpressed with a cluster of neural-specific TFs supports that theory, but still needs 
further investigation. ZNF536, a heavily regulated node in the network, is known to be 
expressed in the developing brain and is shown to be a manor repressor of neural 
development genes [159]–[161]. This indicates that its role in this network is more of a 
repressive role in order to control the neural development and pace it, as the levels of the 
known neural TF NEUROD1 increase, it promotes further the expression of ZNF536 which 
in its turn slows down neural differentiation. NEUROD1 is a TF known to be essential for the 
survival and maturation of neurons as well as having the ability to reprogram certain 
reactive cells into functional neurons [162]–[166] and regulates in the intra-network the 
expression of PAX6 and ZNF536. FOXP2 peaking in Day 60 is a TF known to be involved 
directly in speech and language skills as well as its involvement in directing neural 
development [167]–[170] and seems to be one of the direct targets of PAX6. VSX2, another 
target of PAX6 that co-expresses it is known to be specific for the development of the visual 
system [171]–[174]. ATOH7, just like NEUROD1 is a regulator of PAX6 and ZNF536, is known 
for its involvement in photoreceptor development and neurogenesis in the retina [175]–
[178]. ATOH7 is a high candidate for being one of the master regulators of neurogenesis, but 
a further experimental investigation needs to be performed. Three other TFs of Day 60, 
POU4F2, INSM2, and RORB, don’t appear in the intra-network due to their lack of 
involvement in intra-regulatory interactions. There exists evidence that POU4F2 is involved 
in fish retina development [179][180], and in this case, we might hypothesize that it is 
involved in human retina and neural development as well. INSM2 is a tumor repressor, and 
little is known about its role in neural development; however, a hypothesis can be made 
about its role being similar to ZNF536 in terms of control of the neurogenesis and pacing the 
cell growth. RORB is known for its role in photoreceptor development  [181][182] and also 
interestingly associated with the bipolar disease, which we can hypothesize is due to its 






Figure 43.  The intra-regulatory network corresponding to Day 60. FOXP2 is heavily regulated 
by the TFs of the previous stage, with 4 incoming inter-regulatory edges. 
 
Studying the targets of the Day 60 TFs, we queried the regulatory network for targets of 
these TFs that have a correlation between -0.7 and 0.7 to its regulator and resulted in 193 
target genes. These target genes were enriched for terms very specific to neural 
development, such as the central nervous system and neuron differentiation and neuron 






Table 15. The GO terms enriched in the targets of Day 60 TFs. 











cerebellum development  107 9 1.02 8.79 + 1.47E-02 
metencephalon development  116 9 1.11 8.10 + 2.75E-02 
positive regulation of synaptic transmission  146 10 1.40 7.15 + 2.22E-02 
central nervous system neuron differentiation  184 11 1.76 6.24 + 2.42E-02 
regulation of synapse structure or activity  235 13 2.25 5.78 + 6.78E-03 
neuron projection morphogenesis  494 27 4.73 5.71 + 6.92E-09 
gliogenesis  221 12 2.12 5.67 + 2.19E-02 
plasma membrane bounded cell projection 
morphogenesis  498 27 4.77 5.66 + 8.27E-09 
cell projection morphogenesis  502 27 4.81 5.62 + 9.88E-09 
synapse organization  280 15 2.68 5.60 + 1.39E-03 
regulation of synapse organization  224 12 2.14 5.60 + 2.50E-02 
axonogenesis  381 20 3.65 5.48 + 1.51E-05 
cell part morphogenesis  524 27 5.02 5.38 + 2.55E-08 
cell morphogenesis involved in neuron 
differentiation  443 22 4.24 5.19 + 5.93E-06 
positive regulation of neuron projection 
development  290 14 2.78 5.04 + 1.19E-02 
 
Furthermore, we investigated whether the TFs of Day 60 collaborate in the regulation of 
the target set, and for that, we utilized the PC-TraFF algorithm. We ran the extended 
version of the PC-raff algorithm, searching for potential TF  collaborations that utilize the 
PWMs associated with the TFs of Day 60 in the promoter regions of the correlated target 
set of these regulators. The maximal distance between the pairs was chosen as 20, and the 
z-score cutoff was 3 in the first attempt, and subsequently the maximal distance was 
adjusted to 100, and the Z-score cutoff was 3 , yet neither of these attempts leads to the 











Figure 44. A co-expression cluster of TF genes that are active through the whole process of 
cardiac differentiation and the expression patterns of some of the important TFs in this cluster. 
 
Using the co-expression workflow, a group of regulators was detected with an expression 
pattern in the form of a span starting from Day 3 or Day 8 and ending after Day 29 when 
cardiac maturation has happened. Regulators have different temporal spans during cardiac 
development in which they are active thus probably used (Figure 44). These temporal spans 
can give a hint about the type of role these regulators play. In contrary to the peaking TFs 
detected in the TRC, this group of TFs seems to be important throughout the whole cardiac 




possibly be responsible for different kinds of processes and tasks that are more general and 
needed at every stage of the differentiation. For that, we did deeper literature research on 
the known roles of these TFs and analyzed their target sets.  
Some of these regulators, such as TBX20, GATA4, and NKX2-5, are known to be among the 
handful core regulators that are essential for cardiac differentiation.  TBX20 is a well-known 
conserved TF that plays a fundamental role in cell proliferation and the development of the 
heart, particularly the cardiac chamber and valve formation [184]–[199]. TBX20 is also 
proven to act as a dual repressor and activator during the development of the heart [186] 
[199] as well as directly interacting with NKX2-5, GATA4, and GATA5 [197].  From the 
expression pattern, TBX20 seems to be not involved in the early cardiac development or the 
formation of the mesoderm layer as it is not expressed yet in Day 3; however, its expression 
goes up in Day 8 when the cardiac specification starts and is maintained till the 
cardiomyocytes are mature. GATA4 is another essential cardiac TF that is required for the 
formation of the heart tube and the ventral morphogenesis and can cause congenital heart 
defects when mutated [124], [126], [200]–[207]. GATA4 seems to have an expression head 
start on the other TFs in this cluster as its expression level starts to increase already at Day 
3 then continues to increase peaking at Day 8, maintaining its expression through the cardiac 
differentiation decreasing again towards the end of the differentiation. This makes GATA4 a 
potential master regulator and higher in the hierarchy among this group as it is expressed at 
stage Day 3 when the others are not expressed yet, revealing its independence from the other 
and even a potential role in activating them. NKX2-5, another core regulator of cardiac 
development, is detected in this group, is known to regulate early cardiac-specific 
transcription and other cardiac functions in the adult heart [208]–[212]. NKX2-5 is closer in 
its activity pattern to TBX20 than to GATA4, associating it to a similar set of processes that 
TBX20 might be involved in. 
 
5.4.3 Chromatin Modification Analysis 
I ran a co-expression analysis on the histone genes in the gene set, and one main cluster 
peaking at D3 appeared in the analysis (Figure 45). The cluster consisted of: HIST1H3G, 
HIST1H2BO, HIST1H1D, HIST1H1B, HIST1H2BG, HIST1H2BI, HIST1H3F, HIST1H4C, 
HIST1H2AH, HIST1H2BF. The GO enrichment of this set, as expected, showed terms related 
to chromatin accessibility and DNA packaging. 
Day 3 is a time point that coincides with the mesoderm induction stage and precedes the 
early cardiac specification. Thus, a hypothesis can be made about the involvement of such 
genes in Day 3 in opening the chromatin, making the promoters of wider sets of TFs and 
target genes accessible for certain TFs to start a regulatory cascade leading to cardiac 
development. Another explanation of this early activity of these genes could be the necessary 







Figure 45. The cluster of histone genes with their expression patterns peaking at Day 3. 
 
Table 16. The GO enrichment of the Histone genes detected in the Day3 cluster. 











nucleosome assembly  116 5 .03 > 100 + 3.12E-07 
chromatin assembly  133 5 .04 > 100 + 6.08E-07 
chromatin assembly or disassembly  154 5 .04 > 100 + 1.25E-06 
nucleosome organization  157 5 .04 > 100 + 1.37E-06 
DNA packaging  177 5 .05 98.85 + 2.47E-06 
protein-DNA complex assembly  208 5 .06 84.12 + 5.45E-06 
regulation of gene silencing  127 3 .04 82.66 + 4.09E-02 
protein-DNA complex subunit organization  250 5 .07 69.99 + 1.35E-05 
DNA conformation change  291 5 .08 60.13 + 2.85E-05 
chromatin organization  695 6 .20 30.21 + 1.21E-05 
cellular protein-containing complex assembly  793 5 .23 22.06 + 4.07E-03 







Figure 46. The main regulators that potentially regulate the expression of the histone genes. 






Figure 47. The expression of HMGA1, which is high before the differentiation starts drops as it 
starts and remains low. 
We used the regulatory workflow on the Day 3 histone genes, asking for correlated TFs that 
regulate at least one gene in the set. HMGA1 stood out as a TF that is able to regulate 6 out of 
7 of these histone genes (Figure 46), which can potentially indicate its role as a master 
regulator or one of the essential regulators necessary for chromatin remodeling via 
activating histone genes that code for chromatin unwrapping protein. The down-regulation 
HMGA1 is known to be crucial for chromatin composition in the context of myogenic 
differentiation [213]. The interaction of the HMGA1a protein with the chromatin is also well 
documented, as HMGA1 has been found to alter the chromatin structure by interacting with 
the transcription machinery, resulting in negative or positive regulation of the 
transcriptional activity of several genes [214]–[216]. Interestingly underexpression of 
HMGA1 (Figure 47) is also associated with cardiac hypertrophy, which is the abnormal 





5.5 Early cardiac differentiation  





Figure 48. The TRC of the early cardiac differentiation based on the C20 cell line. Below are the 
main relevant GO terms for three of the stages. 
We ran the TRC workflow on the C20 derived cardiomyocytes dataset, which included four 
time points with two replicates each. The time points were focused on early cardiac 
differentiation, thus provided a high temporal resolution for the days Day 0 to Day4 followed 
by a gap after which the mature cardiomyocytes were examined and sequenced. The 
resulting TRC consisted of four time points, where each time point had 12 associated 
regulators and the regulatory interactions between them we constructed (Figure 48).   
First, we inspected the GO enrichment of the regulators of each stage, picking from the terms 
that had a p-value>0.05, those with the highest fold enrichment. Regulators of the first time 
point showed enrichment of terms related to stem cell maintenance, which goes naturally 
with the biological context since the process of differentiation had not started yet, and the 
cells are still maintained in the induced stem cell state. These regulators are probably 
essential for maintaining the pluripotency state and also could potentially be repressing 
differentiation.  Regulators of Day 2 show enrichment of terms associated with mesenchymal 
and mesoderm morphogenesis, which are the initial steps to giving rise to cardiac cells. 
Regulators of the last stage, the Cardiomyocyte (CM) stage, show high enrichment of very 
specific terms that are related to heart development such as cardiac ventricle and chamber 
formation, ventricular cardiac muscle differentiation, heart looping, and outflow tract 
morphogenesis.  These terms show a high consistency with the underlying stage of 
differentiation reported by the experiment.  
 
Next, we dived in deeper by inspecting each regulator and regulatory interaction in the 







Figure 49. The intra-regulatory network corresponding to Day 0 in the C20 cell line of the early 
cardiac differentiation dataset. 
In the first time point, TFs associated with maintaining the pluripotency state like 
NANOG[218], PARP1, SOX2 [219] [220], MYC [221], ETV4 and ETV5[222] appear.  
CDX1 and CDX2, which are known to modulate early cardiogenesis peak at Day 2, alongside 
some potentially important early cardiac regulators such as TCF4 and LEF1. On Day 4, MYCN 
stands out with a high outdegree and indegree confirming its known role in heart 
development [223] alongside some potential candidate regulators such as LHX1, OTX2, 
NR2C1, MIR548Y. The last stage where the cardiomyocytes have already matured, features 
core regulators essential for cardiac development such as MEF2C, HAND2 [224]–[227], 
NKX2-5 , MEIS2 [228], MITF [229], FOXP1 [230] and some new candidate regulators that 






Figure 50.  The intra-regulatory network corresponding to Day 2 in the C20 cell line of the early 
cardiac differentiation dataset. 
 
 
The intra-network of Day 2 is heavily connected (Figure 50). On the peripherals, SP5 regulates 
three essential regulators TCF4 CDX1 and LEF1, and VEZF1 regulates four regulators. These 
2 factors might be the candidate factors that have the potential to kick off the activation 
process of the rest of the regulators in the stage. TCF4 is a central node in this network, being 
heavily regulated and regulating multiple TFs as well as regulating itself. LEF1 also the main 




as well stand out as heavy regulators of this network, conforming with their essential role in 
early heart development 
 
 
Figure 51.  The intra-regulatory network corresponding to Day 4 in the C20 cell line of the early 
cardiac differentiation dataset. 
 
 
The intra-network of Day 4 shows a relatively small number of intra-regulations compared 
to the other stages (Figure 51). Two microRNAs, MIR548Y and MIR98, are predicted to 
regulate the expression of the essential TFs, MYCN, SMAD4, and HAND1.   
 
On the peripherals of the CM network, we observe NKX2-5, JUN, FOS, CEBPD as regulators 
that regulate the other same stage regulators but yet not regulated by any of them (Figure 52). 
We can hypothesize that these TFs are expressed slightly earlier than the others in this stage 




stage. FOXP1 is heavily regulated by the other TFs, and so is HAND2 without regulating any 
of the other TFs. MEF2A and MEF2C have high betweenness centrality in this subnetwork 
and tend to regulate many of the same target TFs, suggesting either the redundancy of their 
regulatory role  and the robustness of the network against the deletion of one of such 
essential central nodes. However, another hypothesis can be made about the potential 
collaboration between the two TFs and the potential necessity of them both binding to the 
promoters of the common target TFs for the activation to happen.  MEIS2 stands out as a 
self-regulating TF gene that regulates and is regulated by multiple TFs reinforcing its already 





Figure 52.  The intra-regulatory network corresponding to the cardiomyocytes maturation 




5.5.2 MicroRNAs Analysis 
 
We ran a co-expression analysis using only the microRNAs present in the data, to analyze the 
expression behavior dominant in the microRNAs, which is usually dominated by the 
expression patterns of other genes and TFs due to the significantly different small number 
of microRNAs compared to other genes. The co-expression network showed the existence of 
4 clusters (Figure 53) with different expression patterns, three stage-specific, and one 
unspecific (Figure 54). However, the main focus was on the most significant cluster, a cluster 
that contained 10 microRNAs that are unexpressed except in the end at the CM stage. This 
cluster we refer to as the CM specific microRNA cluster. While not a lot of information is 
known about the 10 microRNAs, we hypothesize that they might be involved in cardiac 
development possibly by controlling the proliferation in the end by repressing the involved 
genes. Their role might be similar to the roles of some microRNAs that control cardiac 
hypotrophy such as MIR218 and MIR133 [231][232].  Cardiac hypotrophy is the result of the 
abnormal enlargement of the heart muscle cells, and those microRNAs control negatively the 
expression of genes associated with the growth of these cells. Since the microRNAs observed 
in the cluster are only expressed after the differentiation is finished and knowing that the 




Figure 53.  The co-expression network based on the microRNAs present in the early cardiac 







     
 
 






5.5.3 Collaborating TFs 
We ran the extended version of the PC-raff algorithm, searching for potential TF  
collaborations that utilize the PWMs associated with the TFs of the CM stage in the promoter 
regions of the correlated target set of the CM regulators. The maximal distance between the 
pairs was chosen as 100, and the z-score cutoff was 3. Six significantly collaborating PWM 
pairs were detected (Table 17), among which one pair, the V$CEBP_C - V$CEBPB_Q6, was 
specific for this gene set. These pairs were either associated with CEBPD  collaborating with 
each other or associated with NKX2-5 and NKX2-6 and collaborating with each other. This 
indicates the potential usage of CEBPD for proximal binding sites for bigger complexes or 






Table 17. The potentially collaborating PWM pairs in the promoters of the target set of the TFs 
of the CM stage. 
Matrix 1 Matrix 2 Z-score Background Difference 
V$CETS1P54_02 V$CETS168_Q6 3.368573889 -0.000133862 
V$NKX25_01 V$NKX25_Q6 3.009133379 -0.000393057 
V$CETS168_Q6 V$CETS1P54_03 5.451870726 -0.001390073 
V$CEBPB_01 V$CEBPB_Q6 3.427644453 -0.001031102 
V$NKX25_01 V$NKX25_Q5 3.64831424 -0.000235006 





5.6 Neural precursors 
5.6.1 TRC Analysis 

















































































Upon the visual inspection of the cascade, we observe a missing time point that is Day 2, 
indicating that this time point does not have any peak strength or any genes that exceed the 
certain correlation threshold to the TPP, suggesting that Day 2 might be a time point that 
doesn’t underly any unique stage-specific activity (Figure 55). 
Examining the GO enrichment of each time point reveals high enrichment of relevant terms 
among the regulators active at Day 1 and Day 11.  Regulators of Day 1 showed enrichment 
for specific terms such as cell and neuron fate commitment, neuron differentiation, and cell 
differentiation in the spinal cord.  Regulators of Day 11 showed high enrichment of even 
more specific terms such as spinal cord association neuron differentiation, dorsal spinal cord 
development, cell fate determination, cell differentiation in the spinal cord, hindbrain 
development.  On the other hand, examining the GO enrichment based on the DEG analysis 
publicly available for the same dataset, differentially expressed genes in Day 0 vs.  Day 1 and 
Day 0 vs.  Day 11 showed no significant enrichment of specific terms associated with neural 
development but rather more general terms. Interestingly the expression patterns show that 
most genes that are peaking in one of these two stages have a slight peak also in the second.  
Table 18. The GO enrichment of Day 1 TFs. 











neuron fate commitment  68 4 .03 > 100 + 1.41E-04 
cell differentiation in spinal cord  55 3 .02 > 100 + 1.48E-02 
cell fate commitment  248 5 .11 47.03 + 2.64E-04 
neuron differentiation  1012 6 .43 13.83 + 8.46E-03 
regulation of transcription by RNA polymerase II  2294 8 .98 8.14 + 1.50E-03 
regulation of transcription, DNA-templated  3467 9 1.49 6.06 + 8.26E-04 
regulation of nucleic acid-templated transcription  3534 9 1.51 5.94 + 9.80E-04 
regulation of RNA biosynthetic process  3539 9 1.52 5.93 + 9.93E-04 
animal organ development  3197 8 1.37 5.84 + 2.03E-02 




regulation of cellular macromolecule biosynthetic  
process  3908 9 1.68 5.37 + 2.42E-03 
regulation of nucleobase-containing compound  
metabolic process  4040 9 1.73 5.20 + 3.26E-03 
regulation of macromolecule biosynthetic process  4046 9 1.73 5.19 + 3.31E-03 
regulation of cellular biosynthetic process  4185 9 1.79 5.02 + 4.48E-03 
regulation of biosynthetic process  4264 9 1.83 4.92 + 5.30E-03 
system development  4424 9 1.90 4.75 + 7.38E-03 
 
Table 19. The GO enrichment of Day 11  TFs. 











spinal cord association neuron differentiation  14 3 .01 > 100 + 4.71E-04 
dorsal spinal cord development  22 3 .01 > 100 + 1.59E-03 
cell fate determination  42 3 .02 > 100 + 9.76E-03 
cell differentiation in spinal cord  55 3 .03 > 100 + 2.12E-02 
neuron fate commitment  68 3 .03 92.63 + 3.91E-02 
retina development in camera-type eye  148 4 .07 56.75 + 4.79E-03 
eye morphogenesis  151 4 .07 55.62 + 5.18E-03 
hindbrain development  153 4 .07 54.89 + 5.45E-03 
central nervous system neuron differentiation  184 4 .09 45.64 + 1.12E-02 
cell fate commitment  248 5 .12 42.33 + 5.23E-04 
visual perception  220 4 .10 38.17 + 2.25E-02 
sensory perception of light stimulus  223 4 .11 37.66 + 2.37E-02 






Figure 56. The intra-regulatory network of Day 1. 
A deeper look into the intra-regulatory network of Day 1 (Figure 56) shows OLIG1 and OLIG3, 
which are known for their importance in neural and spinal development [233]–[235], 
suggesting that their importance lies in the earlier part of the differentiation.  A microRNA, 
MIR3659, peaking at Day 1 is heavily regulated by four TFs in the intra-regulatory network, 
which raises the question of the nature of its involvement in neural differentiation, which 
needs to be further investigated. GATA2 is a well-known neural TF proven to control the 
proliferation of the neural progenitors  and drives them into differentiation [236]–[241]. 
GATA2 regulates three other TFs in the network VSX1, MECOM, and OLIG3, which makes it 
a candidate to be a master regulator of that stage. VSX1 is known to have an essential role in 
the retina spinal cord and brain development [242]–[245], and here we observe its 
importance in the earlier stages of neural development, which is consistent with the 
evidence of its role in regulating prechordal mesendoderm. MECOM, BHLHE23, GSX1and 
EBF2 are not well studied or annotated in the context of neural development; however, their 
pattern and association with the other TFs of this stage suggest its candidacy for being 
important neural TFs and can be a good set to test experimentally in the context of neural 
differentiation.  TFAP2C, an active node in the Day 1 network regulating 2 other TFs as well 
as itself, is a known neural and developmental TF that regulates transcription by opening 






PAX2 in Day 11, with the highest outdegree, regulates 13 different regulators in the same 
and next time point which hints that its known essential role in neural development 
[249][250][251]–[255] is due to its regulatory impact on a big set of neural regulators (Figure 
57). LHX5 and LHX1 are both associated with neuronal differentiation, particularly in the 
forebrain [256]–[263].  POU6F2 is associated with renal and neuronal development [264]. 
HSF4 is a regulator involved in the mammalian lens development [265]; however, its 
existence in this neural network suggests that its role in the lens development might be in 
developing the neural connections needed for the lens. TBR1 is another neural regulator that 
is associated with diseases such as autism and proven to regulate neural stem cell fate, which 
explains the fact that it is heavily regulated by the other TFs. LBX1 is known to be important 
in the neural patterning process [266]–[269]. 
KLF2 in Day 5 stands out as a significant potential regulator of the Day 11’s regulatory wave 
due to its potential ability to regulate a big portion of Day 11 regulators.   
The TRC shows an overall same-stage presence of certain TFs that belong to the same family 
or subfamily according to the classification of TFs in TFClass, such as OLIG1, OLIG3, and 




BHLHE23 in Day 1, STAT1 and STAT6 in Day 5, the LHX1 and LHX5 in Day 11 , DBX1 and 
DBX2 in Day 18 .  A hypothesis can be made that these TFs are part of the redundancy that 
leads to the robustness of such regulatory programs, or that these families and subfamilies 
of TFs collaborate in certain regulatory stages. 
 
5.6.2 MicroRNA Analysis 
 
A co-expression analysis was performed on the microRNAs in the dataset, and a large cluster 
along with some smaller clusters was observed, but they all had comparable patterns Figure 
58. Almost all microRNAs peaked up at Day 1 and Day 11, which coincides exactly with the 
two stages where the stage-specific TFs showed a significant neural enrichment. The main 
cluster has two sharp peaks, while the others had a pattern that showed an increase that 
started already on Day 5 in the second wave Figure 59. 
Again in this dataset, as we observed in the early cardiac differentiation dataset, a wave of 
microRNAs accompanies and goes in parallel with the wave of differentiation TFs, possible 
to titrate and control the TF activity. 
  

















6.1 Sampling flaws and solutions 
The TRC model is heavily dependent on the choice of time points in the experiment. The 
model performs optimally and as intended when each underlying stage, for example, a 
differentiation stage, is represented by one and only one time point in the data (Figure 60). 
In many good experimental designs, this condition is satisfied; however, some other 
experiments generate temporal datasets that suffer from over or under-sampling. These 
datasets, if untreated and analyzed through the TRC workflow, can generate a TRC that is 
flawed, or missing information that could have been otherwise recovered. This section 
tackles the problems associated with these datasets and devises methods and modifications 




Figure 60. A good choice of sampling which generates an optimal temporal dataset for the TRC 
analysis. Each biological stage is represented by one and only one time point.  
 
In the under-sampling scenario, the TRC model is suspectable to generate some false 
negatives and some false positives in the stage-specific regulators' sets. False negatives 
appear in the form of genes that were stage-specific however are not identified and false 
positives appear in the form of genes that are not stage-specific in reality; however, they 
appear in a stage-specific gene set. Figure 61 illustrates this problem, where the expression 
of a gene in the dataset doesn’t reflect the complete expression pattern of the gene in reality. 
Stages that were not sampled and no time points are associated with, will be missed.  If a 
gene is highly expressed or peaking in that missing stage, it will be missed by the TRC model 
leading to false negatives. False positives occur when a gene peaks at the missing stage and 
another stage, however only one peak is captured as the other peak is missing from the data, 










Figure 61. An example of the under-sampling problem. Although Stage 2 is a distinct biological 
stage, it has no associated time point. The pattern on the left shows the real expression pattern 
of  a gene that is not stage-specific. In reality, it is peaking in both stage 2 and stage 4; however, 




Although the intuition says that more data points mean more information and better results, 
this is not the case in the TRC model, particularly when the samples are not annotated 
properly. In the over-sampling scenario, the TRC model is suspectable to generate some false 
negatives. Figure 62 illustrates an example of this problem, where two samples are taken 
from the same stage and yet annotated as two distinct time points and not replicates. A gene 
can be stage-specific and have a peaking pattern in reality; however this peak is destroyed 
by redundant time points as it will peak across two consecutive stages, rendering its peak 



































Figure 62. An example of the over-sampling problem. Two redundant time points are sampled 
from the same biological stage and not denoted as replicates. The pattern on the left shows the 
real expression pattern of  a gene that is stage-specific, associated specifically with stage 3 in 
reality. However, due to the redundancy between T3 and T4, its pattern appears to be non-
peaking and is assumed by the TRC model to be not stage-specific. 
 
 
To deal with this particular problem, we devised several solutions: 
1. Time point deletion: Keeping one of these time points and deleting the other 
redundant ones, can eliminate the noise caused by such redundancy, but the challenge lies 
in detecting which time points are the redundant ones and which one to keep out of them. 
These time points can be decided based on two approaches: 
First Approach:  
a. Delete time points one by one and calculate the TRC.  
b. Calculate the PSC for each round of deletion.  
c. The time point that leads to the max PSC when deleted is the potential redundant one. 
 



























a. Calculate the correlation of the gene expression vector between each time point and 
the other.  
b. Time points that show a high correlation are often redundant in their gene expression 
vector, and one of them is to be eliminated.  
c. The time point that shows the higher average correlation with the rest of the time 
points is the candidate to be removed among the two. 
 
Although several time points can be detected and deleted with these approaches, in practice, 
a time series dataset typically contains an average of five time points, and the deletion of 
more than one can lead to scarcity in the time points decreasing the information value of the 
resulting TRC. It is advisable to restrict the elimination to only one time point in medium-
sized time-series datasets (58 time points) and increase the elimination size as the size 
increases. 
2. Using a multiple-time point peak TPP: Instead of using the conventional one-peak 
pattern, using a TPP where the peak extends through several consecutive time points that 
represent one stage can overcome the redundancy issue (Figure 63).  
 
Figure 63. A multiple-time point TPP. The peak spans across T3 and T4 which are two time 
points corresponding to the same stage. 
Determining which time points the peak should span across can be determined by two 
approaches: 
First Approach: 
a. Create a library with one TPP peaking at two consecutive time points, and the other 
TPPs are single peaks for the other time points. 
b. Calculate the resulting TRC based on these libraries. 











Second Approach:  
a. Similar to the second approach in the time point elimination method.  
b. The correlation is calculated between each pair of consecutive time points, and those  
with the highest correlation create a subsequent multiple peak TPP. 
3. Analyzing the experimental procedure: While this approach is not computational, 
it takes into consideration the underlying case under study. A scientist can judge based on 
the observations and markers detected in each time point whether there is a redundancy in 
any time point and if there is a need to remove any of it. This approach can always be coupled 
with any of the above approaches to enhance the decision making leading to the generation 





6.2 Emerging properties and patterns 
 
 
Specific regulatory patterns emerge in the TRC model due to the nature of the methodology. 
These patterns reflect particular regulatory modes, and a glimpse of the relative positions of 
connected nodes can give an idea of the nature of the underlying regulatory interaction. 
 
Unlike some of the classic regulatory models, the TRC model takes advantage of the 
sequential order of the time series data to allow more intricate interpretations of regulatory 
interactions. 
 
One property emerging from the peaking patterns is that each node in the cascade is 
positively correlated in its expression pattern to the other nodes in the same stage as they 
share a strong positive correlation to the same TPP, making their peaking profiles correlated 
as well. This means that each intra-regulatory edge is coupled with a positive correlation.  
Figure 64 is an example of such a regulatory interaction indicating that X is potentially one 
of the activators of Y and contributes to its peaking pattern, where Y is inactive where X is 
inactive and activated when X is activated (stage i), coupled with the fact that X can bind to 
the promoter of Y, this hypothesis of the  regulatory influence of X on Y is strongly enforced. 
Figure 64 has a one-direction property  that supports the causality, whereas cases such as 
the double edge displayed in Error! Reference source not found. cannot decisively assert 
whether X is an activator of Y or the other way around due to  the non-causal nature of 
correlation and the double potential of these regulators to bind in each other's promoters.         
 






Another property emerges from the fact that each TPP in a library is time-lagged correlated 
with every other TPP in the same library. This makes every node in the cascade, which is 
based on a TPP, correlated via a time-lagged correlation to the nodes in the other stages. This 
means that every inter-regulatory edge represents a highly conserved binding site 
prediction of the source in the promoter of the target, coupled with a time-lagged correlation 
where the source regulator needs a certain time to reach a certain threshold of expression 
before it can activate the target. Figure 66 is an example of where a regulator in a certain 
stage potentially needs more time to activate the target; thus, the target is activated after a 
time lag and captured in the next stage. This time delay in the regulation process is studied 
in some cases and fits in many biological contexts including cell differentiation [270].  
 
Thus, each edge in the cascade is always coupled with a correlation between the expression 
pattern of the regulator and its target. This coupling can be viewed as a reinforcement of the 
regulatory interaction predictive quality and gives it an edge over interactions based solely 
on the binding site analysis or solely derived from gene expression data. From another view, 
the binding site prediction behind the edge can explain the perceived correlation in the 










Another common hypothesis that surrounds co-expressed genes is that they might be co-
regulated by a master regulator or a set of master regulators. Some of these master 
regulators can be captured through configurations in the cascade where a regulator 
emerging in a stage single-handedly has the potential to activate a wide set of correlated 
regulators, whether  in the same stage as in the case of Figure 67 or a set of targets in the 
next stage via a  time-lagged regulation as shown in Figure 68. 
 
 
Figure 66. A regulatory interaction from one stage to the next, coupled with a high positive time-
lagged correlation. 
Figure 67.  X a potential master regulator of  Y, Z  and V ,coupled with a high positive correlation 




                                                              
Figure 68. X a potential master regulator activating Y, Z, and V coupled with 







6.3 Parameter adjustment 
Adjusting the parameters can be a big factor in generating a better TRC. This adjustment 
should be based on a good understanding of the data and the questions in scope. Deciding on 
these parameters could be based on the quality of the dataset, inspecting the average 
expression levels, minimum and maximum of the genes in the dataset, and the number of 
time points and replicates in the dataset. 
 
 A very low minE would lead to noise in the cascade caused by very lowly expressed 
regulators, and a high minE could lead to missing on important regulators. While it has 
always been a question of debate, that has no definitive answer to which expression level 
threshold constitutes an expressed gene. One way we used in our work is looking at the mean 
and median of the expression values in a dataset to pick an expression threshold, typically 
close to the mean. However, another way would be looking at specific markers that are 
known to be expressed at a certain time point and basing the minE threshold on their 
average expression value or using the accompanying proteomic data, if available, to deduce 
what expression levels correspond to a gene being translated.  
 
A low minC could lead to certain stages appearing to be significant when in reality they don't 
have any significantly peaking regulators, and a high minC could miss out on regulators that 
are peaking but not perfectly. This parameter has the least impact on the resulting TRC as 
the workflow will always rank the stage-specific regulators based on their correlation to the 
TPP, so even if the threshold was low, and many genes with low peak strength made it to the 
stage-specific list, they will be filtered out and the top minS ones are chosen. However, when 
the minS is large, this threshold becomes more significant. In datasets with a large number 
of replicates per time points, minC can be loosened up as the perfect correlation will be 
harder to achieve as all the replicates have to satisfy the required peak and sometimes the 
small variability between the replicates can produce some noise. 
 
A low minS will also miss some important regulators with a not-perfectly-peaking pattern 
and could lead to a loss of significant GO terms due to the small data set size per stage, and a 
high maxS could overwhelm the cascade with insignificant regulators and make the cascade 
harder to inspect visually. A recommended way to go about this parameter is to increase it 
with datasets of a low number of time points to capture more regulators and increase it with 
those that have a larger number of time points to limit the number of regulators in the TRC. 
However, any minS greater than 20 is not recommended as the TRC becomes harder to 





6.4 TRC comparative analysis 
 
TRCs derived from distinct datasets can be compared to derive insights on the similarities 
and differences in the stage-specific regulators' sets. For this purpose, I developed a 
workflow that facilitates the visual comparison of two TRCs. 
The comparative workflow takes two TRCs and compares the node of the second to the 
nodes of the first, producing a hybrid TRC that highlights the shared genes and their stage 
color code. The colors of the nodes in the first TRC are neutralized by changing their color 
into one unified color, typically not among the node colors in the second TRC to be compared 
with. The node colors in the second TRC are left as they are. The neutralized first TRC is used 
as the basis for the result, then the common nodes between the two TRCs are colored based 
on their color in the second TRC ().  
Figure 70 shows the TRC resulting from the overlap of a TRC based on the H9 early cardiac 
differentiation dataset with the primary cascade based on the heart development dataset 
described in the results. Upon examining the resulting overlap, it is apparent that the colors 
are not scattered randomly across the TRC, and the temporal order of the colors is rather 
preserved. For example, the overlapping genes that are specific to Day 3 in the primary 
cascade are captured either on Day 2 or Day 4 in the H9 cascade. This indicates the 
robustness of the methodology against different time point selections in different 
experiments, enabling it to still capture the same important stage-specific regulators despite 
these differences.  
Another observation we can derive from this comparison is that the overlapping genes from 
Day 3 in the primary cascade show four genes that appear earlier than the other two. This 
gives us a hint to the regulatory precedence of genes like CDX1 in activating the other Day 3 












































































































Figure 70. The resulting TRC from comparing the H9 early cardiac differentiation dataset with 
the heart development dataset.The stage color codes in the primary cascade are displayed on 






6.5 Enrichment vs. correlation 
                    
                        
Figure 71. Different relative TF-Target expression patterns of some of the TFs and targets found 
based on the enrichment in the regulatory network. The expression patterns are indicators that 
some of these predicted regulatory interactions are false positives. 
The web service provides two methods to filter the queried potential regulators or targets 
of  a set of genes, enrichment, and correlation.  
The enrichment analysis uses a hypergeometric test to check for statistically significant 
regulators or targets, in the background network, that regulate or are regulated by a large 
percentage of the genes in the input list, but it ignores their expression value.  
The correlation-based filtering, on the other hand, looks for those regulators and targets in 
the network that are also correlated to the input genes in the query, thus taking into 
consideration the relative expression values.  
A statistically significant predicted TF could be completely unexpressed in the case of 
HOXD10 in Figure 71. , thus it cannot have activated its predicted target GSG. Or the predicted 
target can be expressed in far later stages that the regulation prediction would have been 
meaningless, like in the case of HOXC10 and its target MESP2. Or the expression patterns of 
the TF could be completely fluctuating with respect to the target that a direct regulatory 
interaction or strong influence might be highly unlikely despite the binding site possibility 





While not all regulators and targets are correlated, those that are correlated can be 
indicators of an active regulatory interaction, particularly that it is coupled by binding site 
prediction.  Thus, the correlation-based filtering can lead to potential false negatives but 
potentially to a larger percentage of true positives and lower false positives. On the other 
hand, the enrichment-based filtering can lead to many false-positive context-based 
regulatory interactions as it is only based on the regulatory network. As our focus is on 
providing smaller, context-dependent networks with lower false-positive regulatory 
interactions, we recommend by default the correlation-based filtering of the regulatory 
networks. However, the choice of the filtering can be dependent on the different questions 





6.6 Other template libraries 
Different biological processes use different regulatory programs and modes of regulation. 
For cell differentiation, the single peak pattern works compatibly, but for biological contexts 
such as diseases, immune response, stress response, and others, different template patterns 
might lead to capturing the significant regulators particular to that context. In this section, 
we devise some libraries and template patterns that can be used for different contexts. 
One template pattern library that can be used for disease contexts and stress responses is 
represented in Figure 72. The library is composed of template patterns that capture genes 
that start being expressed after a certain time of exposure to stress or for example, a viral 
infection. This would help expose the temporal regulatory waves that follow up as a stress 
response. 
 
Figure 72. A TPP where the expression goes up and stays up after a the associated time point. 
Another template pattern that can be used to construct a library is a multiple-stage span 
pattern. This is particularly useful when looking for more general regulators that govern the 






Figure 73. A multi- time point pattern for detecting more general TFs. 
 
The anti-peak pattern is a pattern that is exactly opposite to the default TPP (Figure 74).   
The anti-peak pattern associated to time point t is an expression pattern constructed such 
that the expression is: 
 -  100   at time point  t. 
 -    0    at every other  time point. 
 
Figure 74. An anti peak template pattern associated with T3. 
 
This pattern can provide the basis to generate a TRC that can help capture the stage-specific 
repressors. While the regulatory interactions, in this case, will be meaningless as the 
repressors within the same stage are not expressed to regulate each other or to regulate the 
upcoming stage, the list of repressors and their association with each stage can be very 




correlated target genes and uncover insights about the repressive regulatory forces and their 
temporal role. 
Other libraries such as shut down genes after a certain stage lead to capturing the patterns 
where certain genes are shut off after a certain time point of being exposed to a stress or a 
disease, leading to a TRC that has a different interpretation than the single peak one but can 





6.7 TRCs and proteomics 
The mRNA serves as a blueprint for protein synthesis, however not all mRNA fragments get 
translated to proteins, and a single mRNA fragment can be used more than once by different 
ribosomes to produce multiple polypeptides. All these variables and factors make the 
relationship between the mRNA and protein levels a non-direct one. 
Although it is mostly applied to RNA-Seq, the model itself is not exclusive to data based on 
mRNA levels. Theoretically, the same workflow can be applied to good quality proteomic 
time-series data when available, to detect spikes in the protein levels, corresponding to 
certain genes and detect their stage specificity. However, these spikes in the protein levels 
are not as sharp or frequently occurring as those observed for the mRNA due to their low 
turnover rate. 
Some studies suggested that though not linear, the relationship between the protein levels 
and the mRNA exists at a certain level. Genes with high mRNA levels will have a higher 
protein to mRNA ratio than lowly expressed mRNAs [271][272]. Other studies have even 
attempted to calculate these relationships for each gene individually [273]. These 
relationships can be used to estimate the protein levels of the genes in the cascade or for 
filtering out those that have no definite relationship between their mRNA and protein levels 
from the stage-specific regulator’s sets. 
Moreover, the cascade can provide small candidate sets for the proteomic investigation. The 
protein levels of the stage-specific regulators of the relevant time points or of the whole 
cascade can be measured, as a second step after the RNA-Seq measurement, using the same 






6.8 Shuffling and randomization 
 
The TRC analyses on various datasets, including the ones analyzed in the results section, 
showed clear stage-specific regulatory waves and a GO enrichment that is highly consistent 
with the biological context of the experiment and, even more specifically, the context in the 
particular time points of the experiment.  
The question arises whether these peaking profiles and case-specific GO enrichments are 
statistically significant, and constitute a characteristic of developmental gene expression 
datasets in particular, or if they randomly occur in any dataset.  
While applying the TRC model thousands of times to a large number of random and shuffled 
datasets and evaluating the resulting TRCs would be optimal to proof the statistical 
significance of the results, it is merely unfeasible due to the manual process of assessing the 
resulting TRCs. Alternatively, we applied the model to randomly generated and shuffled gene 
expression datasets aiming towards a comparative analysis rather than a statistical proof of 
significance. We examined the resulting TRCs in terms of the GO enrichment of the stages to 
evaluate their relevance compared to a TRC generated from a real experimental dataset.  
The first test involved shuffling the heart development dataset by re-assigning genes to other 
expression profiles to check whether any set of peaking regulators will show a specific GO 
enrichment, and none of the stages did lead to any relevant terms. The test was repeated by 
shuffling the regulator's profiles only, and the enrichment was again insignificant. The 
previous test showed that the identity of the peaking genes is essential, precise, and specific. 
 In the second test, the workflow was applied to the heart development dataset without 
restricting the stage-specific sets to only regulator genes (Figure 75). The generated cascade 
was overwhelmed by non-regulatory genes, and the GO enrichment showed the enrichment 
of very few cardiac-related significant terms and only in one of the stages. The cardiac-
specificity of the GO terms in this TRC is much lower than the original regulators-only TRC. 
This could be due to the fact that non-regulator genes are less annotated in the GO than 
regulatory genes, or simply that the effect of a handful of non-regulatory genes is not as 
impactful as a handful of regulators in determining the fate of cell differentiation. This 
observation supports the choice in the TRC model of limiting the cascade to regulators where 
less relevant non-regulatory genes do not dilute the small stage-specific gene sets.  
In the third test, the  heart development  dataset was shuffled by permuting all the values in 
the expression matrix. The result was again a lack of significance in GO the enrichment terms.  
The last test was applying the TRC workflow to a randomly generated gene expression 
dataset, using the gene names and the time points from  the heart development  dataset 
combined with randomly generated expression values. The GO enrichment showed an 







Figure 75.  TRC generated without the restriction to regulators. The absence of the regulatory 













6.9 TF families in TRCs 
Through the analysis of more than 30 different datasets using the TRC model, an interesting 
pattern of behavior of TF families became apparent. We observed the relative patterns and 
associated stages of TFs belonging to the same family in each TRC and categorized it into two 
main modes of behavior. 
The first mode is represented in a heavy same-stage appearance of multiple TFs belonging 
to the same family. An example of this would be CDX1, CDX2, HOXA1, and HOXB1 which 
belong to the HOX family and appear to peak in the same stage in the early cardiac 
differentiation TRC.  We hypothesize that these TFs have rather redundant roles, competing 
for the same binding sites and adding robustness for the regulatory programs at that stage. 
However, a further investigation of the similarities of the protein structure of these TFs can 
confirm or lead to different hypothesis. 
 
The second mode is represented in the rather successive appearance of members of the same 
family across stages. We hypothesize that these TFs have distinct roles where each of them, 
at a certain stage, occupy a set of binding sites that is reused by another TF of the same family 






6.10 Application to non-temporal datasets 
Although the TRC model is designed to be applied for temporal gene expression datasets, it 
can be adapted for any gene expression dataset with multiple conditions. The TRC model can 
detect condition-specific regulators and regulatory networks the same way it detects stage-
specific ones (Figure 76). Regulators are identified based on their peak in a specific condition 
and their low expression in all the others.  The inter-regulatory edges in this case are 




Figure 76. A TRC applied to a simulated multiple-conditions dataset. The regulators that are 
peaking in one tumor type and not the others are detected as well as the regulatory interactions 
between them. The cross edges between the columns are meaningless in this case as they are 




6.11 Comparison with other tools 
Although the model is different in its methodology and output than many of the current 
popular methods, we attempted to compare the results of applying 3 popular methods 
STEM, iDREM and DEG analysis to the TRC generated by our model. We used the same 
dataset, the heart development  dataset for this comparison. 
6.11.1 STEM 
We applied the STEM tool to the heart development dataset using the default parameters in 
the STEM interface. The result is a list of statistically significant gene expression profiles and 
the associated gene list with each profile (Figure 77). 
Upon examining the top 10 profiles, we cannot see any stage-specific pattern as most of the 
profiles have a rather fluctuating pattern making a conclusion about the role of the genes 
associated with these profiles unclear. 
The GO terms enriched for each of the associated gene lists in the significant profiles were 
examined as well. An absence of cardiac-related terms or even cell differentiation contexts 
was common through the GO enrichment analysis of all of the top 10 sets. 
 
Figure 77. The top significant gene expression patterns predicted by STEM in the heart 





In the first run of iDREM, the human_predicted_1000 reference network provided by the tool 
was used as a background regulatory network, and the HMM model was generated and 
displayed (Figure 78).  The model contained over 100 predicted bifurcation points. Each 
bifurcation point had a list of associated TFs. We examined the GO enrichment and the 
identity of the regulators at the critical bifurcation points. While main stage-specific cardiac 
regulators such as MEF2C, ISL1, and other important cardiac TFs were not identified in any 
of the bifurcation point TF sets generated by iDREM, it managed to identify some cardiac TFs 
that were not identified by the TRC model such as GATA4 and NKX2-5 , as important TFs in 
a bifurcation point in Day 8.  iDREM seems to have an advantage on the TRC model in 
capturing general TFs whose expression span over multiple time points, but lacks in 
capturing stage-specific TFs in comparison to the TRC. When it comes to performance, 
iDREM took several hours per run compared to few seconds that TRC workflow required to 
generate its cascade. 
 
Figure 78. The HMM output of the analysis of the heart development  dataset using iDREM. 
Each node in the model represents a bifurcation point, and not a gene as in the TRC. Each 










The GO enrichment of the gene lists was examined, and was overall found to be low on 
significant cardiac-related genes particularly when compared to the GO enrichment of the 
stage-specific sets generated by the TRC model (Figure 79). 
6.11.3 DEG Analysis 
Table 20 shows the enrichment of the DEG lists generated by a previously published study 
on the heart development  dataset [274]. Examining the size of the generated DEG lists shows 
significantly bigger lists per time point compared to the lists generated by the TRC model. 
These big lists hold a drawback when it comes to choosing candidate genes to test since a 
manual, or further computation reduction has to be made before a practical set of candidates 
can be identified for experimental inspection. On the other hand, examining the GO terms 
resulting from the enrichment of such lists, no direct cardiac-relevant terms are observed, 







Table 20.  The top terms of the GO enrichment of the DEG lists generated in a previously 
published study on the heart development  dataset.  
Stage Number 




            
             429 
 vesicle transport along actin filament 
 positive regulation of protein localization to    plasma 
membrane 
 actin filament bundle assembly 
 regulation of protein tyrosine kinase activity  




             
            1241 
 positive regulation of rRNA processing 
 positive regulation of ribosome biogenesis 
 positive regulation of transcription of nucleolar large 
rRNA by RNA polymerase I 
 DNA replication-dependent nucleosome assembly 
 regulation of rRNA processing 
Late Cardiac 
Specification 
              36  L-cystine transport 
  amino acid transmembrane transport 
Early Cardiac 
Maturation 
             204  cellular metabolic process 
    
Late Cardiac 
Maturation 
           
             975 
 negative regulation of vesicle fusion 
 postsynaptic density protein 95 clustering 
 positive regulation of protein localization to synapse 








In this thesis, I developed the concept of temporal regulatory cascades (TRCs) in the form of  
a model that was implemented as an interactive web-service. I then applied the method in 
order to analyze different temporal gene expression datasets and examined the results from 
a biological point of view to derive new knowledge and compare it to the existing literature 
and experimental  knowledge. 
The TRC method utilizes a collection of template peak patterns (TPPs) and a background 
general regulatory network. Each TPP that has a peak at one of the time points is then used 
to attract genes, typically regulators, which are specific for a certain stage. These sets of 
stage-specific regulators are organized based on their temporal order in a cascade formation. 
The background regulatory network is based on TF binding site predictions and provides the 
source for querying the regulatory interactions between stage-specific regulators, which are 
represented in the form of edges in the TRC.  
The TRC method was implemented as the main workflow in a web-service that contains 
other related and interconnected workflows. The user can visually explore questions related 
to co-expression and co-regulation in his dataset, refining gene sets of interest and 
investigating the effects of different regulatory sets to end up with biologically sensible 
results. 
The TRC workflow was applied to different temporal datasets that revolved around cell 
differentiation experiments. The stage-specific regulators’ sets were investigated and 
evaluated using GO enrichment and the literature knowledge and were found to be highly 
consistent with the underlying biological stages and events. Previously-known important 
regulators and temporal regulatory interactions were identified as well as new, potentially 
significant ones. 
The method suffers from sensitivity to the experimental design and choice of time points. 
However, several solutions were devised in this manuscript to work around this problem. 
On the other hand, the TRC method computationally out-performs other popular methods 








While in this manuscript I presented the core TRC model, this model can be expanded in 
different directions, by  adding features and methods to cover more biological scenarios and 
hypotheses. On the other hand, the webtool is flexible enough to incorporate various 
features, methods, and relevant links. Hereby I present a set of features that, had the time 
allowed, would have been implemented to enrich the current method even more. These 
outlooks can provide the basis for the next version of the method in case it is upgraded and 
extended by me or any fellow scientist. 
 
One main feature that can be added is a collection of context-dependent libraries that cover 
different biological contexts such as disease, stress response, drug reaction. These libraries  
can be used accordingly for different datasets that are relevant to these contexts. This 
enables a wider set of users to use the model effectively.  
 
Another feature that can be extended in the model is giving the option for a user to construct 
his own template library and building the cascade. This feature would enable the user to 
visually construct the template patterns of interest based on his knowledge about the time 
points and the questions in mind and constructing a TRC around it. The interface, in that case, 
would include a graph featuring artificial expression patterns of a regulator and its target, 
where the user can drag the patterns constructing an ideal relative position. 
One powerful addition to the method would be linking the evaluation of the stage-specific 
gene sets to a semantic ontology. The ontology would then evaluate the GO terms and detect 
those that are biologically relevant to the case. This evaluation would be based on a set of 
keywords provided by the user about the experimental context and keywords for each 
particular time point. Such a feature will enable optimizing the model and its parameters to 
generate the most biologically relevant cascade, where the density of case-relevant stage-
specific regulators is maximized. Moreover, it will allow the automatic evaluation of the 
cascade, which translates into an ability to benchmark the model, calculate its significance 
statistically, and compare it to other methods. 
Chromatin accessibility information such as ATAC-seq, ChIP-seq, and DNase-seq, when 
available in the experiment, would provide a very good addition to the current model. These 
data can be integrated in various ways to enrich the model or validate the predictions. 
Regulatory predictions, for example, can be filtered based on the availability of the promoter 




additional evidence for a regulatory prediction that might be occurring at a particular time-
point.  
As different technologies of measuring gene expression evolve, methods and models to 
analyze the output evolve in parallel. We hope that the methods described in this thesis can 
provide one useful way to approach the puzzle of gene expression and regulation, and merely 
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Abstract
Cell differentiation is a complex process orchestrated by sets of regulators precisely
appearing at certain time points, resulting in regulatory cascades that affect the expression
of broader sets of genes, ending up in the formation of different tissues and organ parts.
The identification of stage-specific master regulators and the mechanism by which they
activate each other is a key to understanding and controlling differentiation, particularly in
the fields of tissue regeneration and organoid engineering. Here we present a workflow
that combines a comprehensive general regulatory network based on binding site predic-
tions with user-provided temporal gene expression data, to generate a a temporally con-
nected series of stage-specific regulatory networks, which we call a temporal regulatory
cascade (TRC). A TRC identifies those regulators that are unique for each time point,
resulting in a cascade that shows the emergence of these regulators and regulatory inter-
actions across time. The model was implemented in the form of a user-friendly, visual web-
tool, that requires no expert knowledge in programming or statistics, making it directly
usable for life scientists. In addition to generating TRCs the tool links multiple interactive
visual workflows, in which a user can track and investigate further different regulators, tar-
get genes, and interactions, directing the tool along the way into biologically sensible
results based on the given dataset. We applied the TRC model on two different expression
datasets, one based on experiments conducted on human induced pluripotent stem cells
(hiPSCs) undergoing differentiation into mature cardiomyocytes and the other based on
the differentiation of H1-derived human neuronal precursor cells. The model was success-
ful in identifying previously known and new potential key regulators, in addition to the par-
ticular time points with which these regulators are associated, in cardiac and neural
development.
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Introduction
Cell differentiation, the building block of development, is a strong representation of regulatory
precision. In stem cell differentiation, a handful of regulators kick off a regulatory mechanism
that leads to the activation or repression of other regulators and non-regulatory genes, through
consecutive waves, starting processes that are geared towards specification and giving rise to
different kinds of cells and tissues [1–5]. The discovery of induced pluripotent stem cells
(iPSCs) [6–8], opened the door to a rising number of cell differentiation experiments. Owing
to the decreasing prices of RNA-seq, these experiments generated a big and growing number
of time series datasets that aim to track a certain process of differentiation by taking snapshots
of the gene expression at different time points. These datasets could be further analyzed to
obtain a better extensive explanatory model of the regulatory processes and to identify new
important regulators that can be manipulated to enhance the process. Deriving as much infor-
mation as possible from such experiments is a crucial goal in the fields of medical and biologi-
cal research [9–13], yet there is still a need for computational methods that analyze such
unique models in a way tailored to their special properties.
One common challenge to the researchers in these fields is identifying a set of candidate
genes that are crucial for the study case, from the thousands of genes in the dataset, that if
manipulated can impact the quality and the outcome of the process under study. This candi-
date set has to be small enough to make the experimental validation of each candidate feasible.
One approach is constructing co-expression networks, clustering the genes into modules, usu-
ally large ones, then attempting to reduce these modules based on topological feautures [14].
Other approaches, like Short Time-series Expression Miner (STEM), find statistically signifi-
cant gene patterns and the genes associated with them [15]. Differential gene expression
(DEG) analysis is one of the most popular methods to create lists of genes that can be stage-
associated. DEG lists provide a good start but often are large in size, and the stage-specific reg-
ulators often get diluted in more general genes leading to rather general GO terms when
enriched. TFRank [16] is a popular network-based prioritization method, but it doesn’t inte-
grate time series expression data. There are other different approaches to prioritize genes and
reducing gene lists resulting from previous methods [17], yet none of these specifically take
into account the unique properties of cell differentiation.
Another challenge lies in identifying and understanding the important regulatory interac-
tions and programs that trigger and control the expression of different essential genes. One of
the most useful and general approaches to address these regulatory programs is via construct-
ing gene regulatory networks (GRNs), typically a directed graph with the genes as nodes and
the edges connecting the nodes usually indicating the regulatory interactions. In the past years,
many methods and models have been developed to construct GRNs based on either expression
data [18], Chip-seq, binding sites analysis, or other data types and models. Some of these mod-
els depend solely on one data type to build these networks while others more effectively com-
bine one or more data sources. Despite the general success of some methods which derive
GRNs from gene expression data, they have commonly known limitations, such as the inability
to deal with time series data in the case of Bayesian Networks (BNs), excessive computational
time in the case of Dynamic Baysian Networks (DBNs), and the fact that the number of genes
is mostly greater than the number of experimental conditions can cause problems when it
comes to methods like Graphical Gaussian Models (GGMs) and BNs [19, 20]. Another differ-
ent approach is using binding site analysis in the genome to predict the capability of transcrip-
tion factors (TFs) to regulate the expression of target genes. TFs have the potential to bind to a
DNA region via a binding site with a specific pattern of nucleotides that can be recognized by
the DNA-binding domain (DBD) associated with each TF. The challenge in this approach lies
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mainly in finding the proper library of positional weight matrices (PWMs), the ideal thresh-
olds, and cutoffs and defining the regions of search. The result is an extensive regulatory net-
work that covers a large number of potential regulatory interactions. While these regulatory
effects are potentially possible, only a subset of these interactions takes place in a specific con-
text and time. Finding these subsets and refining the global regulatory network according to
the biological context under study would result in a more meaningful and case-relevant
network.
To tackle these challenges, we constructed a novel workflow and a model of a regulatory
network that incorporates the element of time and temporal order, integrates the expression
levels of genes, is concise enough to be inspected visually, and identifies candidate regulators
efficiently. The method is time and memory efficient, yet it generates a model with a specific
architecture to display the primary transcriptional regulators, such as TF genes and miRNAs,
and regulatory events unfolding with time. It pre-computes an extensive gene regulatory net-
work that is based on binding site analysis, is independent of the expression data and is used as
a background regulatory network. The workflow then uses expression data to identify stage-
specific regulators based on their expression pattern. These regulators are finally organized in
a cascade architecture that we call a temporal regulatory cascade (TRC). In a TRC, master reg-
ulators specific for each stage are organized in ordered vertical columns, and potential regula-
tory interactions that are based on the background network are displayed as edges between
these regulators. To demonstrate this model, we developed an online tool aimed for experi-
mentalists as well as bioinformaticians interested in investigating the regulatory forces that
might explain the observed expression of genes in a particular time series dataset. Our novel
workflow offers the automatic generation of a TRC from an uploaded time series dataset and
visualizes it in an animated interactive manner. In order to facilitate direct interpretation, the
results at any stage of the workflow are distilled to an amount that can be handled and analyzed
visually, keeping the top significant genes, interactions, and information and discarding those
with lower significance and specificity.
In this manuscript, we describe the workflow in detail and report on its application to two
time series expression datasets. Both datasets characterize the differentiation of pluripotent
stem cells into mature cardiac myocytes and neural progenitors, and the corresponding TRC
was generated and analyzed in each case. The main aim was to analyze the specific regulatory
activity in each stage, identify and evaluate regulators specific for each time point in the differ-
entiation process, and to test the efficiency of the workflow in re-identifying some well-known
case-relevant regulators and regulatory interactions without prior knowledge.
Materials and methods
Background regulatory network
A library of position weight matrices (PWMs) from TRANSFAC1 [21] is used in combination
with the MATCH™ [22] program to predict transcription factor binding sites (TFBSs) in the
conserved promoter regions of the human genome as follows.
Based on 49,344 RefSeq-annotated human transcription units (UCSC track refGene, Jan.
22, 2014), the -1kb upstream region was selected as a proximal promoter. The transcription
start site (TSS) indicated in RefSeq was used as the reference point.
On the basis of pre-calculated whole genome alignments provided by the UCSC (46_
WAY_MULTIZ_hg19) these promoter definitions were utilized to retrieve the sequence con-
served regulatory regions between human (hg19), mouse (mm9), dog (canFam2) and cow
(bosTau4). Afterwards, gaps resulting from the multiple genome alignment were removed.
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MATCH was used to predict potential TFBSs in the previously identified conserved pro-
moter regions, based on all vertebrate defined matrices using the PWM library from TRANS-
FAC (release 2013.1, 1446 vertebrate matrices). All matrices with default minFN threshold
(minimize false negatives) were used in order to predict potential TFBSs that have at least the
quality of an annotated TFBS in TRANSFAC. 1360 out of 1446 TRANSFAC-PWMs had a
sequence-conserved TFBS prediction. We ranked all predicted TFBSs associated with each
PWM, according to their MATCH score. We chose the best 5% predicted binding sites for
each PWM and constructed the background transcriptional regulatory network accordingly.
The PWMs are translated to human TF-gene names (HGNC-defined) using the TRANSFAC
database. Each TF-gene, identified by its official HGNC-defined gene name, was represented
as a node, with a directed edge connecting it with its target gene node. Further information
about the construction of the regulatory network can be found in our previous manuscript
[23].
The core network included 829 TFs and their 16354 targets, summing up to 749949 interac-
tions. Another expanded network, which includes microRNA binding predictions, was con-
structed and contained 2239 regulators and 20160 targets. This network was computed once
and is independent in the process of its derivation from the expression data, making it usable
with every human expression dataset.
While the tool offers the user the option to upload a custom regulatory network to be used
for the analysis, we recommend the built-in network just described. The conservation property
of these sites makes the prediction ideal for the differentiation context since several pieces of
research have shown that conserved regions in the DNA are critical binding sites for develop-
ment and differentiation [24–27].
Temporal regulatory cascades (TRCs)
The method utilizes the concept of constructing template expression patterns that represent an
expression behaviour of interest, then attracting genes that behave similarly to these patterns
using correlation. The template patterns we used were stage-specific patterns, peaking at one
time point only, and denoted by template peak patterns (TPPs). While different kinds of tem-
plate patterns can be used, we chose the single-peak TPPs, as a default for its ability to attract
stage-specific regulators that are unique to each time point. Regulatory interactions are queried
from the background regulatory network and form the edges between the genes in the cascade
accordingly.
TRC construction steps.
Step 1: Create a library of TPPs, one TPP for each time point in the dataset. For each time
point the corresponding TPP has an expression level of 100 percent at that time point and
zero every other time point(Fig 1A).
Step 2: For each TPP, calculate the top n correlated regulators to this reference pattern (Fig
1B). These genes are said to be the stage-specific regulators of stage s and are displayed in
the same column (Fig 2). If a time point has no correlated regulators, no column is created
for this stage in the TRC.
Step 3: All regulatory interactions between the regulators of the same stage are mapped,
according to their connections in the background regulatory network, and represented in
the form of directed edges.
Step 4: All regulatory interactions between the regulators of stage s and the next stage are
mapped according to their connections in the background regulatory network and
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represented by directed edges, linking each stage to the next and tying the cascade together
(Fig 2).
Parameters. To adjust the temporal regulatory cascade, we use three primary parameters:
minE: A threshold for gene expression levels. A gene that does not have an expression level
higher than this threshold in any of the replicates or time points is eliminated and omitted
from the calculation that leads to the TRC. This eliminates peaking genes that are lowly
expressed even at their peak.
minC: A minimum correlation threshold. Regulatory genes that have a correlation above this
threshold to the TPP of a stage are kept as the initial set of regulators associated with that
stage.
maxS: The maximum number of genes that can be associated with a specific time point. The
initial regulators associated with a time point based on minC are sorted by their correlation
to the TPP of that stage, and the top n (maxS) regulators are picked to be in the column
associated with the stage. If the initial regulators set has less than maxS genes, then the
whole set is taken. The max number of nodes in the cascade is maxS multiplied by the num-
ber of time points.
Implementation
This workflow was implemented in the form of a web service with an interactive visual web
interface, which eliminates then the need to install any additional software. The algorithm to
generate the TRCs was implemented using Java. In order to display the resulting TRC, a visual-
izer was implemented using JavaScript, utilizing, and extending the Cytoscape library cy.js. The
framework used PHP to manage the files and sessions. The visualizer was embedded in an inter-
active webpage that includes helpful information such as graphs of the expression levels of the
genes in the cascade, tables, and metrics, in addition to direct links to perform GO enrichment
and other workflows in the platform. The web tool is a part of a more comprehensive web service
that revolves around gene regulation and expression data analysis that is under construction.
Data
While any formatted time series data can be used as input, this model performs the best with
RNA-Seq data over other sources of inferior quality and less variability such as microarray
Fig 1. Indetifying stage-specific regulators. (A) The TPP of T2: The template peaking pattern is calculated where the expression is at 100 percent T2
and zero every other timepoint. One TPP for each time point is calculated similarly and the collection of these TPPs form the TPP library. (B) Top 10
regulators that are highly correlated with the previous TPP of T2 and their noticeable T2-specific peaking pattern, these regulators will form nodes in
the T2 column in the TRC, the same is done for every TPP in the library.
https://doi.org/10.1371/journal.pone.0231326.g001
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data. Normalized input data provides a better quality TRC, nevertheless even using the
raw counts leads to reasonably significant TRCs. As study cases to demonstrate the TRC
model, two time series gene expression datasets were used and denoted Dataset1 and
Dataset2.
Fig 2. The TRC workflow. Regulators specific for each time point are grouped in the same column with the same color and sorted by their correlation
to the TPP of that stage. The edges between the two stages and within the same stage are retrieved and mapped from the regulatory network.
https://doi.org/10.1371/journal.pone.0231326.g002
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Dataset1 was assembled using public RNA-Seq data that is captured during the differentia-
tion of H1 derived human neuronal precursor cells (NPCs) across the days 0,1,2,4,5,11, and 18
after induction of neuronal differentiation. Publicly available DEG and GO enrichment analy-
sis on the same dataset was used for comparison. The dataset and the analysis results could be
found in the expression Atlas under the accession E-GEOD-56785. The assembled and format-
ted data can be found in S1 File.
Dataset2 was derived from the normalized expression datasets from the previously pub-
lished study by Qing Liu et al [28], publicly available in the GEO repository under the acces-
sion number GSE85332. We chose one of the four expression datasets available, the RNA-Seq
profiling of the differentiation of C20 derived cardiomyocytes at four stages: pluripotent stem
cells (day 0), mesoderm (day 2), cardiac mesoderm (day 4), and differentiated cardiomyocytes
(day 30). The assembled and formatted data can be found in S2 File.
GO enrichment
To evaluate the relevance of the gene sets in each stage, Gene Ontology (GO) enrichment anal-
ysis using the biological processes and a Fisher’s Exact test on each column in these cascades
was applied using one set at a time as an input. Terms that have a pvalue less than 0.05 after
the Bonferroni correction are sorted by their fold enrichment and the top terms were exam-
ined. These terms were evaluated based on their consistency with the differentiation stage
under observation at that time point.
Results
We applied the TRC workflow to Dataset1 and Dataset2 and generated a cascade for each
study case. In addition to the GO enrichment, detailed literature research was performed,
investigating the roles of the different regulators predicted by the cascade.
Neural differentiation cascade
Upon the visual inspection of the cascade, we observe a missing time point that is day 2, indi-
cating that this time point does not have any peak strength or any genes that exceed the corre-
lation threshold to the TPP, suggesting that day 2 might be a time point that doesn’t underly
any unique stage-specific activity (Fig 3).
Examining the GO enrichment of each time point reveals high enrichment of relevant
terms in day 1 and day 11. Regulators of day 1 showed enrichment for specific terms such as
cell and neuron fate commitment, neuron differentiation, and cell differentiation in the spinal
cord. Regulators of day 11 showed high enrichment of even more specific terms such as spinal
cord association neuron differentiation, dorsal spinal cord development, cell fate determina-
tion, cell differentiation in the spinal cord, hindbrain development. On the other hand, exam-
ining the GO enrichment based on the DEG analysis publicly available for the same dataset,
differentially expressed genes in day 0 vs. day 1 and day 0 vs. day 11 showed no significant
enrichment of specific terms associated with neural development but rather more general
terms.
A deeper look into the identity of the regulators in the cascade shows that OLIG1 and
OLIG3, which are known for their importance in neural and spinal development [29–31], are
active in day 1, suggesting that their importance lies in the earlier part of the differentiation. A
microRNA MIR3659 peaking at day 1 with a high indegree raises the question on the nature of
its involvement in neural differentiation, which needs to be further investigated. PAX2 on day
11, with the highest outdegree, regulates 13 different regulators in the same and next time
point which hints that its known essential role in neural development [32–34] is due to its
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regulatory impact on a big set of neural regulators. KLF2 in day 5 stands out as a potential sig-
nificant regulator of the day 11 regulatory wave due to its potential ability to regulate a big por-
tion of day 11 regulators. The TRC shows an overall same-stage presence of certain TFs that
belong to the same family or subfamily according to the classification experimental conditions
TFs in TFClass [35, 36], such as OLIG1, OLIG3 and BHLHE23 in day 1, STAT1 and STAT6 in
day 5, the LHX1 and LHX5 in day 11, DBX1 and DBX2 in day 18. A hypothesis can be made
that these TFs are part of the redundancy that leads to the robustness of such regulatory pro-
grams, or that these families and subfamilies of TFs collaborate in certain regulatory stages.
Cardiac differentiation cascade
Regulators of the first time point show enrichment of terms related to stem cell maintenance,
which is coherent with the biological context since the process of differentiation has not started
yet, and the cells are still in the induced stem cell state (Fig 4). These regulators could be
Fig 3. Neural differentiation cascade. The TRC generated for the differentiation of neural proginators based on dataset 1 and the following
parameters: minC = 0.6, minE = 4, and maxS = 10.
https://doi.org/10.1371/journal.pone.0231326.g003
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essential for maintaining the pluripotency state and also could be repressing differentiation.
Regulators of day 2 show enrichment of terms associated with mesenchymal and mesoderm
morphogenesis, which give rise to cardiac cells. Regulators of the last stage the cardiomyocyte
(CM) stage show high enrichment of heart-specific terms such as cardiac ventricle and cham-
ber formation, ventricular cardiac muscle differentiation, heart looping, and outflow tract
morphogenesis. These terms show a high consistency with the underlying stage of differentia-
tion reported by the experiment.
Fig 4. Cardiac differentiation cascade. The TRC generated for the differentiation of cardiomyocytes based on
dataset2 and the following parameters: minC = 0.6, minE = 30, and maxS = 12.
https://doi.org/10.1371/journal.pone.0231326.g004
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In the first time point TFs associated with maintanining the pluripotency state like NANOG
[37], PARP1 [38], SOX2 [39], MYC [40, 41], ETV4 and ETV5 [42] appear. CDX1 and CDX2
[43] which are known to modulate early cardiogenesis peak at day 2, alongside some poten-
tially important early cardiac regulators such as TCF4 and LEF1. On day 4, MYCN stands out
with a high outdegree and indegree confirming its known role in heart development [44]
along side with some potential candidate regulators such as LHX1, OTX2, NR2C1, MIR548Y.
The last stage where the cardiomyocytes have already matured, features core regulators essen-
tial for cardiac development such as MEF2C [45], HAND2 [46], NKX2-5 [47], MEIS2 [48],
MITF [49], FOXP1 [50] and some new candidate regulators that could be significant in the
cardiac maturation such as MEF2A and BHLHE40. Like in the previous dataset, a strong
same-stage presence of certain TF family members is observed, such as the members of the
HOX family CDX1, CDX2, HOXA1 and HOXB1 in day 2.
Discussion
Unlike some of the classic regulatory models such as BNs, the TRC model takes advantage of
the sequential order of the time series data to allow more intricate interpretations of regulatory
interactions. It takes advantage of the emerging property from the peaking patterns, that is:
each node in the cascade is positively correlated in its expression pattern to the other nodes in
the same stage (Fig 5A), and correlated via a time-lagged correlation to the nodes in the other
stages (Fig 5C). Thus each edge in the cascade is always coupled with a correlation between the
expression pattern of the regulator and its target. This coupling can be viewed as a reinforce-
ment of the regulatory interaction predictive quality and gives it an edge over interactions
based solely on the binding site analysis or solely derived from gene expression data. From
another view, the binding site prediction behind the edge can explain the perceived correlation
in the expression patterns between the target and the source. Fig 5 summarizes the five com-
mon types of regulatory interactions displayed within the cascade through edge patterns. Fig
5A is an example of a regulatory interaction coupled with high positive correlation indicating
that X is potentially one of the activators of Y and contributes to its peaking pattern. Y is inac-
tive where X is inactive and activated when X is activated (stage i), coupled with the fact that X
can bind to the promoter of Y, this hypothesis of the regulatory influence of X on Y is strongly
enforced. Fig 5A has a one-direction property that supports the causality, whereas cases such
as the double edge displayed in Fig 5B cannot decisively assert whether X is an activator of Y
or the other way around due to the non-causal nature of correlation and the double potential
of these regulators to bind to each other’s promoters. Fig 5C is an example of where a regulator
in a certain stage potentially needs more time to activate the target thus the target is activated
after a time delay and captured in the next stage. This kind of regulatory behavior has been
shown and captured using time-lagged correlation models. Another common hypothesis that
surrounds co-expressed genes is that they might be coregulated by a master regulator or a set
of master regulators. Some of these master regulators can be captured through configurations
in the cascade where a regulator emerging in a stage single-handedly has the potential to acti-
vate a wide set of correlated regulators, whether in the same stage as in the case of Fig 5D or a
set of targets in the next stage via a time-lagged regulation as shown in Fig 5E.
The previous analyses of the two datasets showed clear stage-specific regulatory waves and
a GO enrichment that is highly consistent with the biological context of the experiment and,
even more specifically, the context in the particular time points of the experiment. The ques-
tion arises whether these peaking profiles and case-specific GO enrichments are statistically
significant, and constitute a characteristic of developmental gene expression datasets in partic-
ular, or if they randomly occur in any dataset. While applying the TRC model to a sufficiently
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Fig 5. Different cases of regulatory interactions contained in the TRC model. (A) A one-way regulatory prediction within one stage
coupled with a high positive correlation. (B) A two-way regulatory prediction within one stage coupled with a high positive correlation.
(C) A regulatory interaction from one stage to the next, coupled with a high positive time-lagged correlation. (D) X a potential master
regulator of X, Y, and Z coupled with a high positive correlation to each of its targets. (E) X a potential master regulator activating X, Y
and Z coupled with a high positive time-lagged correlation to each of its targets.
https://doi.org/10.1371/journal.pone.0231326.g005
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large number of random and shuffled datasets and evaluating the resulting TRCs would be
optimal to proof the statistical significance of the results, it is merely unfeasible due to the
manual process of assessing the resulting TRCs. Alternatively, we applied the model to ran-
domly generated and shuffled gene expression datasets (see the supplementary files) aiming
towards a comparative analysis rather than a statistical proof of significance. We examined the
resulting TRCs in terms of the GO enrichment of the stages to evaluate their relevance com-
pared to a TRC generated from a real experimental dataset. The first test involved shuffling
dataset2 by re-assigning genes to other expression profiles (S3 File), to check whether any set
of peaking regulators will show a specific GO enrichment, and none of the stages did lead to
any relevant terms. The test was repeated by shuffling the regulator’s profiles only, and the
enrichment was again insignificant. The previous test showed that the identity of the peaking
genes is essential, precise, and specific. Moreover, the workflow was applied to dataset2 with-
out restricting the stage-specific sets to regulators only. Interestingly, the generated cascade
was overwhelmed by non-regulatory genes and the GO enrichment showed no significant
terms in any of the stages, with the exception of two terms related to cardiac muscle differenti-
ation in the last stage (S1 Fig). This observation supports the choice in the TRC model of limit-
ing the cascade to regulators where less relevant non-regulatory genes do not dilute the small
stage-specific gene sets. Next, dataset2 was shuffled by permuting all the values in the expres-
sion matrix (S4 File). The result was again a lack of significance in GO the enrichment terms.
The last test was applying the TRC workflow to a randomly generated gene expression dataset,
using the gene names and the time points from dataset2 combined with randomly generated
expression values (S5 File). The GO enrichment showed the absence of any relevant significant
terms again.
The default library used in this model is the one-stage peak pattern library, which works
optimally with development and differentiation. However this library can be changed, and
multiple libraries for different biological contexts such as diseases and immune responses can
be developed accordingly, which would require further research or alternatively allowing the
user to construct a custom library in the future.
One drawback of this model is the fact that it does not capture every important regulator,
particularly those regulators that are expressed in multiple consecutive or non-consecutive
time points. However, we argue that the sets of regulators identified by the cascade contain a
large percentage of essential stage-specific regulators which is supported by the GO enrich-
ment. On the other hand, the regulatory network might not cover every TF due to missing
PWM information or lack of conservation. Another more general drawback is the fact that the
model relies on transcript levels which do not translate directly into protein levels, but relative
measures [51] [52] can be a potential method for further analysis whenever protein data is not
available. Moreover, the candidate regulators can provide a small concise set for a proteomic
investigation as a next step in the experiment. The captured regulators can also provide a start-
ing point for further analysis such as target set enrichment analysis, pathway analysis, and
investigating the potential collaboration of regulators using tools such as PC-Traff [53]. The
TRC model merely lays down, in place, some important starting pieces that can be built on to
complete the biological puzzle of developmental regulatory programs.
The unique type of the output of the TRC makes it difficult to accurately compare it to
other existing methods, as no other method has the same definition of a regulatory cascade.
However, we utilized the context-relevance of the GO enrichment of the gene sets predicted by
other methods as a basis for the comparison. We first applied the STEM in order to predict the
top 10 significant gene expression patterns in the cardiac differentiation dataset and evaluated
the GO enrichment of the genes set associated with each of these profiles. The GO enrichment
of these sets showed very general terms not specific to the cardiac differentiation context.
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Next, we applied iDREM [54], which we consider the closest method to the TRC in terms of
inputs and aims, using the cardiac differentiation dataset and the regulatory network provided
by iDREM (human_predicted_1000), to generate a dynamic regulatory network. The resulting
model was in the form of a dynamic regulatory map that highlights major bifurcation events,
each of which has a list of associated regulatory genes. The GO enrichment of these gene lists
showed a mild enrichment of developmental GO terms in some bifurcation points and no
enrichment in most of the others. However, proving the validity of a generated network or cas-
cade requires an actual experimental validation of the predicted regulatory interactions in the
particular cellular context, which is currently unpractical.
This workflow is built within a broader framework dedicated to studying regulation from
different points of view. It blends expression data and a regulatory network and links concepts
such as coexpression and coregulation forming a more extensive tool. Users can interactively
investigate different hypothesis and track different genes and regulators of interest exploring
the regulatory forces governing the time series data, the timing of such forces and the impact
of such regulatory interactions on the expression of genes and regulators.
Conclusion
We developed a workflow to analyze and represent regulatory cascades and a web tool based
on the corresponding model. It takes time series expression data as an input, generates and
visualizes an interactive cascade that identifies relevant and stage-specific regulators associated
with each time point and the interactions between these regulators. The workflow was applied
to multiple datasets that revolved around cell differentiation and was successful in identifying
previously-known TFs relevant to the time points and the cell types, in addition to some new
candidate regulators, as well as pinpointing the time points were unique regulation activities
are emerging. A demo of the web tool is available under TF-investigator.sybig.de/TRC.
Supporting information
S1 File. NPC differentiation (Dataset1). The formatted data expression file based on human
H1-derived NPC differentiation differentiation. This format is ready for upload via the webt-
ool.
(CSV)
S2 File. Cardiac differentiation (Dataset2). The formatted data expression file based on C20
derived cardiomyocyte differentiation. This format is ready for upload via the webtool.
(CSV)
S3 File. Shuffled profile assignment of dataset2. A version of dataset2 where gene profiles
are randomly re-assigned. This format is ready for upload via the webtool.
(CSV)
S4 File. Shuffled dataset2 by permuting the matrix. A version of dataset2 where cells in the
expression matrix are permuted across columns and rows. This format is ready for upload via
the webtool.
(CSV)
S5 File. Random expression values with dataset2 time points and gene names. Random
expression values with time points and gene names taken from dataset2. This format is ready
for upload via the webtool.
(CSV)
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S1 Fig. TRC based on dataset2 where regulatory and non-regulatory genes are included.
Stage-specific gene sets are not restricted to regulators in this example. This allows the TRC to
include peaking non regulatory genes as well.
(TIF)
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Methodology: Rayan Daou.
Software: Rayan Daou.
Supervision: Tim Beißbarth, Edgar Wingender, Martin Haubrock.
Visualization: Rayan Daou.
Writing – original draft: Rayan Daou.
Writing – review & editing: Tim Beißbarth, Edgar Wingender, Mehmet Gültas, Martin
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